Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
35000,,,24755138,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5122351,Antimicrobial activity against Staphylococcus aureus JE2 ssessed as reduction in bacterial growth and measured for 24 hrs by resazurin dye based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120805,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862225,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
35001,,,24755191,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5122353,Antimicrobial activity against Pseudomonas aeruginosa PA14 assessed as reduction in bacterial growth and measured for 24 hrs by resazurin dye based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120805,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862225,<,1,1,<,,MIC,ug.mL-1,,0.04,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.04
35002,,,24759203,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5123318,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 16 to 20 hrs by CLSI protocol based assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120843,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,,IC50,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,0.13
35003,,,24759206,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5123319,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as minimum inhibitory concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120843,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
35004,,,24759209,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5123320,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as minimum bactericidal concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120843,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.5
35005,,,24759213,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5123321,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 incubated for 16 to 20 hrs by CLSI protocol based assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120843,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,,IC50,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,0.12
35006,,,24759216,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5123322,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as minimum inhibitory concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120843,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
35007,,,24759219,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5123323,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as minimum bactericidal concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120843,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,0,=,,MFC,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MFC,ug ml-1,UO_0000274,,0.5
35008,,,24759223,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5123324,Antibacterial activity against Escherichia coli ATCC 35218 incubated for 16 to 20 hrs by CLSI protocol based assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120843,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,,IC50,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,ug ml-1,UO_0000274,,0.01
35009,,,24759224,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5123325,Antibacterial activity against Escherichia coli ATCC 35218 assessed as minimum inhibitory concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120843,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
35010,,,24759225,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5123326,Antibacterial activity against Escherichia coli ATCC 35218 assessed as minimum bactericidal concentration incubated for 16 to 20 hrs by CLSI protocol based assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120843,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862885,=,1,0,=,,MBC,ug ml-1,,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.13
35011,,,24759294,[],CHEMBL5123350,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
35012,,,24759320,[],CHEMBL5123351,Antibacterial activity against Streptococcus pneumoniae 07P390 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
35013,,,24759346,[],CHEMBL5123352,Antibacterial activity against Streptococcus pneumoniae PU09 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
35014,,,24759372,[],CHEMBL5123353,Antibacterial activity against Streptococcus pyogenes 12-206 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
35015,,,24759398,[],CHEMBL5123354,Antibacterial activity against Staphylococcus aureus 15B196 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
35016,,,24759424,[],CHEMBL5123355,Antibacterial activity against Staphylococcus aureus PU32 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
35017,,,24759450,[],CHEMBL5123356,Antibacterial activity against Haemophilus influenzae ATCC 49247 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120845,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862919,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.03
35018,,,24767899,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125448,Antibacterial activity against wild type methicillin resistant Staphylococcus aureus 4561/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
35019,,,24767905,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125449,Antibacterial activity against wild type methicillin resistant Staphylococcus aureus 4968/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
35020,,,24767911,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125450,Antibacterial activity against wild type methicillin resistant Staphylococcus aureus 5017/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
35021,,,24767921,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125451,Antibacterial activity against wild type Staphylococcus aureus 4557/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35022,,,24767932,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125452,Antibacterial activity against wild type Staphylococcus aureus 4463/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35023,,,24767943,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125453,Antibacterial activity against wild type Staphylococcus aureus 4904/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35024,,,24767954,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125454,Antibacterial activity against wild type Staphylococcus aureus 4862/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35025,,,24767965,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125455,Antibacterial activity against wild type Staphylococcus aureus 4883/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35026,,,24767976,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125456,Antibacterial activity against wild type Staphylococcus aureus 4880/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35027,,,24767987,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125457,Antibacterial activity against wild type Staphylococcus aureus 4460/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
35028,,,24767998,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125458,Antibacterial activity against wild type Staphylococcus aureus 4482/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
35029,,,24768009,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125459,Antibacterial activity against wild type Staphylococcus aureus 4566/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35030,,,24768020,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125460,Antibacterial activity against wild type Staphylococcus aureus 4504/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35031,,,24768030,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125461,Antibacterial activity against wild type Staphylococcus aureus 4740/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
35032,,,24768040,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125462,Antibacterial activity against wild type Staphylococcus aureus 4717/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35033,,,24768051,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125463,Antibacterial activity against wild type Staphylococcus aureus 4738/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35034,,,24768062,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125464,Antibacterial activity against wild type Staphylococcus aureus 4461/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35035,,,24768073,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125465,Antibacterial activity against wild type Staphylococcus aureus 4679/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35036,,,24768083,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125466,Antibacterial activity against wild type Staphylococcus aureus 4502/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
35037,,,24768093,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125467,Antibacterial activity against wild type Staphylococcus aureus 4515/A assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
35038,,,24768104,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125468,Antibacterial activity against wild type Staphylococcus aureus 5079/C assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35039,,,24768115,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125469,Antibacterial activity against wild type Staphylococcus aureus 4788/B assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.063
35040,,,24768126,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125470,Antibacterial activity against wild type Staphylococcus aureus 78/CF assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35041,,,24768137,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125471,Antibacterial activity against wild type Staphylococcus aureus 77/CF assessed as reduction in microbial growth incubated for 24 hrs by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
35042,,,24768167,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5125480,Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in microbial growth measured after 20 cycles by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5120927,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864557,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,2.0
35043,,,24786050,[],CHEMBL5130755,Antibacterial activity against Staphylococcus aureus ATCC 6538 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5126636,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3868853,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35044,,,24786067,[],CHEMBL5130756,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5126636,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3868853,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
35045,,,24793181,[],CHEMBL5133093,Antibacterial activity against methicillin-resistant Staphylococcus aureus 197,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
35046,,,24793193,[],CHEMBL5133094,Antibacterial activity against Acinetobacter baumannii ATCC 19606,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,0.5
35047,,,24793205,[],CHEMBL5133095,Antibacterial activity against Acinetobacter baumannii 139,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
35048,,,24793217,[],CHEMBL5133096,Antibacterial activity against Acinetobacter baumannii 140,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
35049,,,24793229,[],CHEMBL5133097,Antibacterial activity against Escherichia coli ATCC 35218,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.008
35050,,,24793241,[],CHEMBL5133098,Antibacterial activity against Escherichia coli 202,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.06
35051,,,24793253,[],CHEMBL5133099,Antibacterial activity against Escherichia coli 203,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,32.0
35052,,,24793265,[],CHEMBL5133100,Antibacterial activity against Neisseria gonorrhoeae ATCC 19424,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.004
35053,,,24793277,[],CHEMBL5133101,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,0.25
35054,,,24793289,[],CHEMBL5133102,Antibacterial activity against Pseudomonas aeruginosa 142,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,32.0
35055,,,24793301,[],CHEMBL5133103,Antibacterial activity against Pseudomonas aeruginosa 143,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,32.0
35056,,,24793313,[],CHEMBL5133104,Antibacterial activity against Streptococcus pneumoniae ATCC 49169,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.5
35057,,,24793325,[],CHEMBL5133105,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
35058,,,24793337,[],CHEMBL5133106,Antibacterial activity against methicillin-resistant Staphylococcus aureus 196,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
35059,,,24793349,[],CHEMBL5133107,Antibacterial activity against Neisseria gonorrhoeae WHO K,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,32.0
35060,,,24793353,[],CHEMBL5133108,Antibacterial activity against Neisseria gonorrhoeae WHO G,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.125
35061,,,24793357,[],CHEMBL5133109,Antibacterial activity against Neisseria gonorrhoeae Barla194,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,32.0
35062,,,24793361,[],CHEMBL5133110,Antibacterial activity against Neisseria gonorrhoeae WHO Q,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.008
35063,,,24793365,[],CHEMBL5133111,Antibacterial activity against Neisseria gonorrhoeae WHO O,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.004
35064,,,24793369,[],CHEMBL5133112,Antibacterial activity against Neisseria gonorrhoeae WHO M,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,2.0
35065,,,24793373,[],CHEMBL5133113,Antibacterial activity against Neisseria gonorrhoeae WHO E,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.002
35066,,,24793377,[],CHEMBL5133114,Antibacterial activity against Neisseria gonorrhoeae WHO C,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.004
35067,,,24793381,[],CHEMBL5133115,Antibacterial activity against Neisseria gonorrhoeae WHO B,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.008
35068,,,24793385,[],CHEMBL5133116,Antibacterial activity against Neisseria gonorrhoeae WHO A,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.002
35069,,,24793389,[],CHEMBL5133117,Antibacterial activity against Neisseria gonorrhoeae WHO Z,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870237,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,32.0
35070,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24794662,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5133361,Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using pNO1 plasmid DNA as substrate incubated for 30 mins by fluorescence based microtiter plate reader assay,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131416,Bioorg Med Chem Lett,2022.0,"{'bei': '16.34', 'le': '0.31', 'lle': '3.84', 'sei': '7.26'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.42,0,http://www.openphacts.org/units/Nanomolar,3870462,=,1,1,=,,IC50,nM,,3840.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,3.84
35071,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24794673,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5133362,Inhibition of Staphylococcus aureus topoisomerase 4 using pNO1 plasmid DNA as substrate incubated for 30 mins by fluorescence based microtiter plate reader assay,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131416,Bioorg Med Chem Lett,2022.0,"{'bei': '15.20', 'le': '0.29', 'lle': '3.46', 'sei': '6.76'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.04,0,http://www.openphacts.org/units/Nanomolar,3870462,=,1,1,=,,IC50,nM,,9160.0,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,,IC50,uM,UO_0000065,,9.16
35072,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24794678,[],CHEMBL5133363,Inhibition of Escherichia coli DNA gyrase by fluorescence based microtiter plate reader assay,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131416,Bioorg Med Chem Lett,2022.0,"{'bei': '20.03', 'le': '0.38', 'lle': '5.06', 'sei': '8.90'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.64,0,http://www.openphacts.org/units/Nanomolar,3870462,=,1,1,=,,IC50,nM,,230.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.23
35073,,,24795270,[],CHEMBL5133455,Antibacterial activity against Staphylococcus aureus NCTC 4163,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35074,,,24795283,[],CHEMBL5133456,Antibacterial activity against Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
35075,,,24795296,[],CHEMBL5133457,Antibacterial activity against Staphylococcus aureus ATCC 6538,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
35076,,,24795309,[],CHEMBL5133458,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
35077,,,24795322,[],CHEMBL5133459,Antibacterial activity against Staphylococcus epidermidis ATCC 12228,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
35078,,,24795335,[],CHEMBL5133460,Antibacterial activity against Staphylococcus epidermidis ATCC 35984,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
35079,,,24795348,[],CHEMBL5133461,Antibacterial activity against Escherichia coli NCTC 10538,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
35080,,,24795361,[],CHEMBL5133462,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
35081,,,24795374,[],CHEMBL5133463,Antibacterial activity against Pseudomonas aeruginosa ATCC 15442,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
35082,,,24795387,[],CHEMBL5133464,Antibacterial activity against Pseudomonas aeruginosa NCTC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
35083,,,24795400,[],CHEMBL5133465,Antibacterial activity against Staphylococcus epidermidis 825/19,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
35084,,,24795413,[],CHEMBL5133466,Antibacterial activity against Staphylococcus epidermidis 829/19,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
35085,,,24795426,[],CHEMBL5133467,Antibacterial activity against Staphylococcus epidermidis 830/19,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,64.0
35086,,,24795439,[],CHEMBL5133468,Antibacterial activity against Staphylococcus epidermidis 834/19,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
35087,,,24795452,[],CHEMBL5133469,Antibacterial activity against Staphylococcus epidermidis 840/19,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
35088,,,24795465,[],CHEMBL5133470,Antibacterial activity against Staphylococcus epidermidis 845/19,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,16.0
35089,,,24795478,[],CHEMBL5133471,Antibacterial activity against Staphylococcus epidermidis 848/19,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
35090,,,24795491,[],CHEMBL5133472,Antibacterial activity against Staphylococcus epidermidis 851/19,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131424,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870560,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
35091,,,24800209,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5134763,Antibacterial activity against pET28a-NDM-1 positive Escherichia coli BL21(DE3) isolates assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131475,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871463,=,1,1,=,,MIC,ug.mL-1,,0.4267,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug/L,UO_0000274,,426.67
35092,,,24800224,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5134764,Antibacterial activity against NDM-1 positive Escherichia coli ZC-YN3 isolates assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131475,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871463,=,1,1,=,,MIC,ug.mL-1,,0.00667,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug/L,UO_0000274,,6.67
35093,,,24801794,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '720.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '30.0'}]",CHEMBL5135013,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth measured after repeated 30 day serial passage treatment by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131487,Bioorg Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3871787,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35094,,,24809378,[],CHEMBL5136537,Antibacterial activity against cystic fibrosis isolate Staphylococcus aureus by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35095,,,24809394,[],CHEMBL5136538,Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35096,,,24809410,[],CHEMBL5136539,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
35097,,,24809426,[],CHEMBL5136540,Antibacterial activity against Staphylococcus aureus 3527 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
35098,,,24809442,[],CHEMBL5136541,Antibacterial activity against Staphylococcus aureus harbouring GyrA D83N mutant by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
35099,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24809457,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.4167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '25.0'}]",CHEMBL5136542,Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity incubated for 25 min by ethidium bromide/bromophenol blue staining based agarose gel electrophoresis analysis,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,"{'bei': '13.74', 'le': '0.26', 'lle': '2.97', 'sei': '6.11'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.55,1,http://www.openphacts.org/units/Nanomolar,3873274,=,1,1,=,,IC50,nM,,28000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,28.0
35100,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24809472,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'min', 'standard_value': '10.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'min', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'min', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'min', 'value': '20.0'}]",CHEMBL5136543,Inhibition of Staphylococcus aureus DNA topoisomerase 4 decatenation activity using kDNA as substrate incubated for 10 to 20 min by ethidium bromide/bromophenol blue staining based agarose gel electrophoresis analysis,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,"{'bei': '15.29', 'le': '0.29', 'lle': '3.49', 'sei': '6.79'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.07,1,http://www.openphacts.org/units/Nanomolar,3873274,=,1,1,=,,IC50,nM,,8600.0,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,,IC50,uM,UO_0000065,,8.6
35101,,,24809487,[],CHEMBL5136544,Selectivity ratio of IC50 for inhibition of Staphylococcus aureus DNA topoisomerase 4 decatenation activity to IC50 for inhibition of Staphylococcus aureus DNA gyrase supercoiling activity,B,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3873274,=,1,0,=,,Ratio IC50,,,0.31,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,0.31
35102,,,24809507,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5136545,Antimicrobial activity against Neisseria gonorrhoeae G strain harbouring type 2 topoisomerase GyrA S91F and ParE G410V mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.12
35103,,,24809528,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5136546,Antimicrobial activity against wild type Neisseria gonorrhoeae ATCC 49226 incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.002
35104,,,24809549,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5136547,Antimicrobial activity against wild type Neisseria gonorrhoeae F strain incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.002
35105,,,24809570,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5136548,"Antimicrobial activity against Neisseria gonorrhoeae K strain harbouring type 2 topoisomerase GyrA S91F, D95N and ParC S87R, S88P mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,>,1,1,>,,MIC,ug.mL-1,,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,1.0
35106,,,24809591,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5136549,Antimicrobial activity against wild type Neisseria gonorrhoeae O strain incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.03
35107,,,24809612,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5136550,Antimicrobial activity against wild type Neisseria gonorrhoeae P strain incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.004
35108,,,24809633,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5136551,"Antimicrobial activity against wild type Neisseria gonorrhoeae V strain harbouring type 2 topoisomerase GyrA S91F, D95G and ParC S87R mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,>,1,1,>,,MIC,ug.mL-1,,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,1.0
35109,,,24809654,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5136552,"Antimicrobial activity against wild type Neisseria gonorrhoeae Y strain harbouring type 2 topoisomerase GyrA S91F, D95G and ParC S87R mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,>,1,1,>,,MIC,ug.mL-1,,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,1.0
35110,,,24809660,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5136553,Antimicrobial activity against wild type Neisseria gonorrhoeae ATCC 49226 incubated for 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.004
35111,,,24809663,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5136554,Antimicrobial activity against Neisseria gonorrhoeae G strain harbouring type 2 topoisomerase GyrA S91F and ParE G410V mutant incubated for 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.12
35112,,,24809666,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5136555,"Antimicrobial activity against Neisseria gonorrhoeae M strain harbouring type 2 topoisomerase GyrA S91F,D95G mutant incubated for 20 hrs by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,2.0
35113,,,24809669,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5136556,"Antimicrobial activity against Neisseria gonorrhoeae L strain harbouring type 2 topoisomerase GyrA S91F,D95N and ParC D86N,S88P mutant incubated for 20 hrs by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5131562,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3873274,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,8.0
35114,,,24814670,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5138131,Antibacterial activity against methicillin-resistant Staphylococcus aureus TCH1516 assessed as growth inhibition incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5136988,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874644,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
35115,,,24814676,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5138132,Antibacterial activity against Escherichia coli LptD4213 assessed as growth inhibition incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5136988,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874644,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
35116,,ND,24819161,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139928,Antibacterial activity against Bacillus cereus ATCC 14579 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,MIC,,,,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,,,,
35117,,,24819199,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139929,Antibacterial activity against Bacillus cereus ATCC 10987 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3875792,=,1,1,=,,MIC,nM,,10700.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,uM,UO_0000065,,10.7
35118,,ND,24819236,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139930,Antibacterial activity against Enterococcus faecalis LMG 08222 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,MIC,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,,,,
35119,,ND,24819274,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139931,Antibacterial activity against Enterococcus faecalis LMG 16216 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,MIC,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,,,,
35120,,,24819312,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139932,Antibacterial activity against Enterococcus faecalis V583 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3875792,=,1,1,=,,MIC,nM,,26700.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,26.7
35121,,ND,24819349,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139933,Antibacterial activity against Enterococcus faecalis LMG 11423 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,MIC,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,,,,
35122,,,24819387,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139934,Antibacterial activity against Enterococcus faecalis LMG 16003 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3875792,=,1,1,=,,MIC,nM,,32000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,32.0
35123,,,24819425,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139935,Antibacterial activity against Staphylococcus aureus LMG 8224 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3875792,=,1,1,=,,MIC,nM,,20800.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,20.8
35124,,ND,24819465,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139936,Antibacterial activity against Staphylococcus aureus LMG 10147 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
35125,,ND,24819503,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139937,Antibacterial activity against Staphylococcus aureus LMG 15975 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
35126,,ND,24819541,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5139938,Antibacterial activity against Clostridium beijerinckii B504 incubated for 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,MIC,,,,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,,MIC,,,,
35127,,ND,24819579,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5139939,Antibacterial activity against Clostridium botulinum CECT551 incubated for 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,MIC,,,,CHEMBL614963,Clostridium botulinum,Clostridium botulinum,1491.0,,,MIC,,,,
35128,,,24819617,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5139940,Antibacterial activity against Clostridium difficile CECT531 incubated for 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3875792,>,1,1,>,,MIC,nM,,32000.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,uM,UO_0000065,,32.0
35129,,ND,24819654,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5139941,Antibacterial activity against Clostridium-ihumii AP5 incubated for 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,MIC,,,,CHEMBL612545,,Unchecked,,,,MIC,,,,
35130,,,24819692,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5139942,Antibacterial activity against Clostridium perfringens CECT376 incubated for 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3875792,=,1,1,=,,MIC,nM,,500.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,uM,UO_0000065,,0.5
35131,,ND,24819731,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5139943,Antibacterial activity against Clostridium tetani CECT 4629 incubated for 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,MIC,,,,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,,,,
35132,,,24819766,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5139944,Antimicrobial activity against Escherichia coli LMG 8224 incubated for 20 hrs by CLSI based broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5137029,J Nat Prod,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3875792,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
35133,,,24837158,[],CHEMBL5144782,Antibacterial activity against rifampicin resistant Staphylococcus aureus harboring RpoBH481Y mutant assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879307,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35134,,,24837193,[],CHEMBL5144783,Antibacterial activity against wild type Staphylococcus aureus assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879307,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35135,,,24837228,[],CHEMBL5144784,Antibacterial activity against ciprofloxacin resistant Staphylococcus aureus harboring ParCS80F and GyrAS84L double mutant assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879307,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
35136,,,24837263,[],CHEMBL5144785,Antibacterial activity against Staphylococcus aureus harboring RpoBH481Y/ParCS80F/GyrAS84L triple mutant assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879307,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
35137,,,24837298,[],CHEMBL5144786,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879307,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
35138,,,24838922,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5144980,Antibacterial activity against Staphylococcus aureus 1199B measured after 24 hrs by Muller Hinton broth based MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143555,Bioorg Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879624,=,1,1,=,,MIC,ug.mL-1,,0.21,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.21
35139,,,24838954,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5144981,Antibacterial activity against Staphylococcus aureus 1199 measured after 24 hrs by Muller Hinton broth based MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143555,Bioorg Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879624,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
35140,,,24838983,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5144982,Antibacterial activity against Staphylococcus aureus K1758 measured after 24 hrs by Muller Hinton broth based MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143555,Bioorg Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879624,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
35141,,,24841340,[],CHEMBL5145634,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143581,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3880169,=,1,1,=,,MIC,nM,,4730.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,4.73
35142,,,24841355,[],CHEMBL5145635,Cytotoxicity in African green monkey Vero cells assessed as reduction in cell viability,T,,,BAO_0000181,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143581,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,3880169,>,1,0,>,,Activity,uM,,100.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,Activity,uM,UO_0000064,,100.0
35143,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24843785,[],CHEMBL5146125,Inhibition of Escherichia coli DNA gyrase supercoiling activity,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,"{'bei': '22.17', 'le': '0.42', 'lle': '5.77', 'sei': '9.85'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,7.35,0,http://www.openphacts.org/units/Nanomolar,3880659,=,1,1,=,,IC50,nM,,45.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.045
35144,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24843794,[],CHEMBL5146126,Inhibition of Escherichia coli topoisomerase 4 assessed as reduction in decatenation,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,7.52,0,http://www.openphacts.org/units/Nanomolar,3880659,=,1,1,=,,IC50,nM,,30.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.03
35145,,,24843808,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146127,Cytotoxicity against human HepG2 cells assessed as reduction in cell viability for 24 hrs by Celltiter-Glo assay,T,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,>,1,1,>,,IC50,ug.mL-1,,128.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,ug ml-1,UO_0000274,,128.0
35146,,,24843836,[],CHEMBL5146128,Antibacterial activity against Acinetobacter baumannii NCTC 13420 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,64.0
35147,,,24843864,[],CHEMBL5146129,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
35148,,,24843892,[],CHEMBL5146130,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
35149,,,24843920,[],CHEMBL5146131,Antibacterial activity against Escherichia coli W4573 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
35150,,,24843948,[],CHEMBL5146132,Antibacterial activity against Escherichia coli N43 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
35151,,,24843976,[],CHEMBL5146133,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35152,,,24844002,[],CHEMBL5146134,Inhibition of human ERG by Ionworks electrophysiology assay,T,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3880659,>,1,1,>,,IC50,nM,,100000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,uM,UO_0000065,,100.0
35153,,,24844032,[],CHEMBL5146136,"Lipophilicity, logD of the compound by shake flask assay",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3880659,=,1,1,=,,LogD,,,-1.2,CHEMBL2362975,,No relevant target,,,,logD,,,,-1.2
35154,,,24844059,[],CHEMBL5146137,Protein binding in mouse plasma by equilibrium dialysis assay,A,,,BAO_0000179,BAO_0000366,cell-free format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,3880659,>,1,1,>,,PPB,%,,30.0,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,,30.0
35155,,,24844067,[],CHEMBL5146138,Protein binding in human plasma by equilibrium dialysis assay,A,,,BAO_0000179,BAO_0000366,cell-free format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,3880659,>,1,1,>,,PPB,%,,30.0,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,,30.0
35156,,,24844112,[],CHEMBL5146148,Inhibition of human topoisomerase 2 assessed as reduction in decatenation,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3880659,>,1,1,>,,IC50,nM,,100000.0,CHEMBL1806,Homo sapiens,DNA topoisomerase II alpha,9606.0,,,IC50,uM,UO_0000065,,100.0
35157,,ND,24844121,[],CHEMBL5146149,Resistance development in Escherichia coli ATCC25922 assessed as spontaneous resistance frequency at 4 times MIC by resistance development assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3880659,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
35158,,,24844140,[],CHEMBL5146160,Antibacterial activity against Escherichia coli ATCC25922 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880659,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
35159,,,24846071,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146737,Antibacterial activity against Staphylococcus aureus ATCC 25293 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881072,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.8
35160,,,24846078,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146738,Antibacterial activity against methicillin resistant Staphylococcus aureus 5076 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881072,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
35161,,,24846085,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146739,Antibacterial activity against methicillin resistant Staphylococcus aureus 5076 harbouring DNA gyrase and topoisomerase IV mutant and efflux pump assessed as inhibition of bacterial growth incubated for 18 hrs in presence of efflux inhibitor by CLSI based serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881072,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
35162,,ND,24871486,[],CHEMBL5153104,Antibacterial activity against Escherichia coli ATCC25922 assessed as prevention of visible growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5150045,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3886720,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
35163,,,24871512,[],CHEMBL5153105,Antibacterial activity against Shigella flexneri CMCC51572 assessed as prevention of visible growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5150045,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3886720,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,,MIC,ug ml-1,UO_0000274,,2.0
35164,,ND,24871538,[],CHEMBL5153106,Antibacterial activity against Salmonella typhi CMCC50094 assessed as prevention of visible growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5150045,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3886720,,1,0,,,MIC,,,,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,,,,
35165,,ND,24871564,[],CHEMBL5153107,Antibacterial activity against methicillin-resistant Staphylococcus aureus 252 assessed as prevention of visible growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5150045,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3886720,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
35166,,ND,24871590,[],CHEMBL5153108,Antibacterial activity against methicillin-resistant Staphylococcus aureus R3708 assessed as prevention of visible growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5150045,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3886720,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
35167,,ND,24871616,[],CHEMBL5153109,Antibacterial activity against Staphylococcus aureus ATCC29213 assessed as prevention of visible growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5150045,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3886720,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
35168,,ND,24871642,[],CHEMBL5153110,Antibacterial activity against Staphylococcus aureus ATCC25923 assessed as prevention of visible growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5150045,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3886720,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
35169,,,24871666,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '256.0', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '256.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '360.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '15.0'}]",CHEMBL5153124,Resistance development in Escherichia coli ATCC25922 assessed as fold increase in resistance after 15 days serial passage upto 256 ug/ml,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5150045,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3886720,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
35170,,,24876663,[],CHEMBL5155010,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154634,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3887678,>,1,1,>,,MIC,nM,,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,100.0
35171,,,24876669,[],CHEMBL5155011,Antibacterial activity against methicillin-resistant Staphylococcus aureus 129 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154634,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3887678,>,1,1,>,,MIC,nM,,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,100.0
35172,,,24876682,[],CHEMBL5155013,Antibacterial activity against methicillin-resistant Staphylococcus aureus 138 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154634,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3887678,>,1,1,>,,MIC,nM,,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,100.0
35173,,ND,24884036,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5156738,Hemolytic activity in human RBC assessed as hemolysis incubated for 2 hrs by spectrophotometer analysis,T,,,BAO_0000375,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL4296518,,Erythrocyte,,,,Activity,,,,
35174,,,24884058,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156739,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 incubated for 24 hrs by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
35175,,,24884099,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156740,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 24 hrs by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.5
35176,,,24884140,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156741,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 incubated for 24 hrs by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.7
35177,,,24884181,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156742,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.7
35178,,ND,24884203,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156743,Antibacterial activity against Enterococcus faecium ATCC 27270 incubated for 24 hrs by microtiter plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,,,,
35179,,ND,24884210,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156744,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 incubated for 24 hrs by microtiter plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,,,,
35180,,ND,24884217,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156745,Antibacterial activity against Enterococcus faecalis ATCC 29212 incubated for 24 hrs by microtiter plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
35181,,ND,24884224,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156746,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 incubated for 24 hrs by microtiter plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
35182,,ND,24884231,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156747,Antibacterial activity against Staphylococcus pneumonia ATCC 49619 incubated for 24 hrs by microtiter plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
35183,,ND,24884238,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156748,Antibacterial activity against multidrug resistant Staphylococcus pneumonia ATCC 700677 incubated for 24 hrs by microtiter plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
35184,,ND,24884245,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156749,Antibacterial activity against Bacillus subtilis ATCC 6633 incubated for 24 hrs by microtiter plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Activity,,,,
35185,,ND,24884252,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156750,Antibacterial activity against Bacillus cereus ATCC 13061 incubated for 24 hrs by microtiter plate method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,Activity,,,,
35186,,,24884259,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156751,Antibacterial activity against Escherichia coli NDM-1-resistant ATCC BAA-2452 incubated for 24 hrs by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.7
35187,,,24884266,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156752,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 ATCC BAA-2470 incubated for 24 hrs by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.5
35188,,,24884273,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156753,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae ATCC BAA-2470 incubated for 24 hrs by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.7
35189,,,24884280,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156754,Antibacterial activity against ciprofloxacin resistance Acinetobacter baumannii ATCC BAA1605 incubated for 24 hrs by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.7
35190,,,24884287,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156755,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 incubated for 24 hrs by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.7
35191,,,24884294,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156756,Antibacterial activity against imipenem resistant Pseudomonas aeruginosa ATCC BAA-1744 incubated for 24 hrs by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.7
35192,,,24884301,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156757,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 incubated for 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,0,=,,MBC,ug ml-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,50.0
35193,,,24884306,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156758,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,0,=,,MBC,ug ml-1,,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,12.5
35194,,,24884310,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156759,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of 150 mM of NaCl by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.5
35195,,,24884314,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156760,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of 4.5 mM of KCl by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.5
35196,,,24884318,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156761,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of 6 mM of NH4Cl by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.7
35197,,,24884322,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156762,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of 1 mM of by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.5
35198,,,24884326,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156763,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of 2 mM of CaCl2 by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.5
35199,,,24884330,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156764,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs in presence of fetal bovine serum by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.5
35200,,,24884333,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156765,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs in presence of 150 mM NaCl by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.3
35201,,,24884337,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156766,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs in presence of 4.5 mM of KCl at by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.3
35202,,,24884341,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156767,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth after 24 hrs in presence of 6 mM of NH4Cl at by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.3
35203,,,24884345,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156768,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs in presence of 1 mM of MgCl2 at by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.7
35204,,,24884349,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156769,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs in presence of 2 mM CaCl2 at by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.3
35205,,,24884353,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5156770,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs in presence of fetal bovine serum by microtiter plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3889015,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.3
35206,,Tde,24884382,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5156784,Bactericidal activity against Escherichia coli ATCC BAA-2452 assessed as reduction of bacterial growth at 4 times MIC by counting formed colonies,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
35207,,Tde,24884387,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5156785,Bactericidal activity against Escherichia coli ATCC BAA-2452 assessed as reduction of bacterial growth at MIC by counting formed colonies,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
35208,,Tde,24884392,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5156786,Bactericidal activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 assessed as reduction of bacterial growth at 4 times MIC by counting formed colonies,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35209,,Tde,24884397,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5156787,Bactericidal activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 assessed as reduction of bacterial growth at MIC by counting formed colonies,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35210,,Active,24884406,[],CHEMBL5156790,Bactericidal activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 assessed as time required for complete reduction of bacterial growth at MIC by counting formed colonies,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35211,,Active,24884413,[],CHEMBL5156791,Bactericidal activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 assessed as time required for complete reduction of bacterial growth at 4 times MIC by counting formed colonies,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154681,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3889015,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35212,,,24894661,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5159206,Antibacterial activity against Methicillin-drug resistant Staphylococcus aureus C0621 incubated for 18 hrs by by disc diffusion method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154746,ACS Med Chem Lett,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3890909,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35213,,,24898326,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/kg/day', 'standard_value': '4.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg/day', 'value': '4.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IP', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IP', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '240.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '10.0'}]",CHEMBL5159906,"Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in 129X1/SvJ NRAMP +/+ mouse gallstone model assessed as log reduction in bacterial burden in gallblader at 4 mg/kg/day, ip administered from 5 to 15 consecutive days and measured on day 15",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154764,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3891386,=,1,0,=,,log(activity),,,3.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,log(activity),,,,3.0
35214,,,24898443,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/kg/day', 'standard_value': '2.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg/day', 'value': '2.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IP', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IP', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '240.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '10.0'}]",CHEMBL5159910,"Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in 129X1/SvJ NRAMP +/+ mouse gallstone model assessed as reduction in bacterial burden in gallblader at 2 mg/kg/day, ip administered from 5 to 15 consecutive days and measured on day 15",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154764,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3891386,,1,0,,,Activity,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,Activity,,,,
35215,,Active,24898456,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/kg/day', 'standard_value': '2.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg/day', 'value': '2.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IP', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IP', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '240.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '10.0'}]",CHEMBL5159917,"Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in 129X1/SvJ NRAMP +/+ mouse gallstone model assessed as reduction in bacterial burden in liver at 2 mg/kg/day, ip administered from 5 to 15 consecutive days and measured on day 15",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154764,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3891386,,1,0,,,Activity,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,Activity,,,,
35216,,Active,24898457,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/kg/day', 'standard_value': '2.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg/day', 'value': '2.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IP', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IP', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '240.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '10.0'}]",CHEMBL5159918,"Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in 129X1/SvJ NRAMP +/+ mouse gallstone model assessed as reduction in bacterial burden in spleen at 2 mg/kg/day, ip administered from 5 to 15 consecutive days and measured on day 15",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154764,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3891386,,1,0,,,Activity,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,Activity,,,,
35217,,,24909965,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162990,Antibacterial activity against Methicillin resistant Staphylococcus aureus ATCC BAA -1556 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893128,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
35218,,,24909978,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162991,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893128,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
35219,,,24909995,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162993,Antibacterial activity against imipenem resistant Klebsiella pneumoniae ATCC BAA 1705 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893128,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,256.0
35220,,,24910008,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162994,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893128,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
35221,,,24912746,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163877,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
35222,,,24912782,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163878,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.125
35223,,,24912818,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163879,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35224,,,24912854,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163880,Antibacterial activity against Staphylococcus aureus 25923 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
35225,,,24912890,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163881,Antibacterial activity against Staphylococcus aureus 29213 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35226,,,24912926,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163882,Antibacterial activity against Klebsiella pneumonia assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
35227,,,24912961,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163883,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
35228,,,24912996,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163884,Antibacterial activity against Escherichia coli 25922 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
35229,,,24913031,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163885,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
35230,,,24913066,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163886,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
35231,,,24913101,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163887,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893676,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
35232,,,24914362,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164231,Antibacterial activity against vancomycin-susceptible methicillin-susceptible Staphylococcus aureus Newman incubated for 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154852,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893975,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35233,,,24914385,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164232,Antimicrobial activity against methicillin-resistant Staphylococcus aureus USA300 LAC incubated for 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154852,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893975,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
35234,,,24914408,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164233,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 incubated for 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154852,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893975,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
35235,,,24914463,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5164245,Cytotoxicity against human L02 cells after 72 hrs by CCK-8 assay,T,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154852,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.91,0,http://www.openphacts.org/units/Nanomolar,3893975,=,1,1,=,,IC50,nM,,12230.0,CHEMBL4296457,Homo sapiens,L02,9606.0,,,IC50,uM,UO_0000065,,12.23
35236,,,24914467,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5164245,Cytotoxicity against human L02 cells after 72 hrs by CCK-8 assay,T,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154852,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893975,=,1,1,=,,IC50,ug.mL-1,,4.05,CHEMBL4296457,Homo sapiens,L02,9606.0,,,IC50,ug ml-1,UO_0000274,,4.05
35237,,,24914471,[],CHEMBL5164246,"Selectivity index, ratio of IC50 for L02 cell cytotoxicity over MIC for vancomycin-susceptible methicillin-susceptible Staphylococcus aureus Newman",T,,,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154852,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3893975,>,1,0,>,,Ratio,,,16.0,CHEMBL612558,,ADMET,,,,Ratio,,,,16.0
35238,,,24915737,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164691,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35239,,,24915761,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164692,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
35240,,,24915785,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164693,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
35241,,,24915809,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164694,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA-1720 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
35242,,,24915833,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164695,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
35243,,,24915857,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164696,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
35244,,,24915881,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164697,Antibacterial activity against Bacillus subtilis CMCC (B) 63501 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.25
35245,,,24915905,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164698,Antibacterial activity against Enterococcus faecium ATCC 49624 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,32.0
35246,,,24915929,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164699,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
35247,,,24915953,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164700,Antibacterial activity against vancomycin resistant Enterococcus faecium ATCC 700221 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,64.0
35248,,ND,24915977,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164701,Antibacterial activity against vancomycin-resistant Enterococcus faecium clinical isolate assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3894259,,1,0,,,MIC,,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,,,,
35249,,,24915999,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164702,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
35250,,,24916021,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164703,Antibacterial activity against Escherichia coli ATCC 8739 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
35251,,,24916043,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164704,Antibacterial activity against NDM-1 expressing Escherichia coli ATCC BAA2469 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
35252,,,24916065,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164705,Antibacterial activity against multi-drug resistant Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,64.0
35253,,,24916087,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164706,Antibacterial activity against penicillin-susceptible Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
35254,,,24916109,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5164707,Antibacterial activity against NDM-1 expressing Klebsiella pneumoniae ATCC BAA 2470 assessed as inhibition of bacterial growth incubated for 20 to 24 hrs by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3894259,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
35255,,,24916206,[],CHEMBL5164742,Induction of drug resistance against Staphylococcus aureus ATCC 29213 assessed as fold increase in MIC after 16 passage,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154863,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3894259,=,1,0,=,,FC,,,512.0,CHEMBL612545,,Unchecked,,,,FC,,,,512.0
35256,,,24920998,[],CHEMBL5166294,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as reduction in bacterial growth by measuring fold increase in MIC after 65 passages by multistep resistance based broth microdilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5154895,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3895184,=,1,0,=,,FC,,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,128.0
35257,,,24959674,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5215481,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,,MIC,ug.mL-1,,0.24,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.24
35258,,,24959686,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5215482,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,,MIC,ug.mL-1,,0.45,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.45
35259,,,24959698,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5215483,Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,,MIC,ug.mL-1,,0.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.9
35260,,,24959714,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5215484,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
35261,,,24959726,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5215485,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,,MIC,ug.mL-1,,0.45,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.45
35262,,,24959738,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5215486,Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition incubated for 16 hrs by microplate reader assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3898908,=,1,1,=,,MIC,ug.mL-1,,0.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.9
35263,,,24959775,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '16.0', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5215499,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in bacterial growth at 16 ug/ml measured after 2 hrs by time-kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3898908,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35264,,,24959781,[],CHEMBL5215505,Induction of drug resistance in methicillin-resistant Staphylococcus aureus assessed as fold change measured after 14 passages,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3898908,=,1,0,=,,FC,,,33.0,CHEMBL612545,,Unchecked,,,,FC,,,,33.0
35265,,Active,24959794,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '5.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5215517,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as presence of erythema at 5 mg/ml,sc measured after 48 hrs",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3898908,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35266,,Active,24959796,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '5.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5215519,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as reduction in skin inflammatory cells at 5 mg/ml,sc measured after 48 hrs by H and E staining based analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3898908,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35267,,Active,24959800,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '5.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5215522,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as reduction in TNF-alpha level at 5 mg/ml,sc measured after 48 hrs by ELISA assay",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3898908,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35268,,Active,24959802,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '5.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5215523,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as reduction in IL-6 level at 5 mg/ml,sc measured after 48 hrs by ELISA assay",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3898908,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35269,,,24959805,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '5.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5215525,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as reduction in microbial burden at 5 mg/ml,sc measured after 48 hrs",F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,3898908,=,1,0,=,,Activity,%,,81.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,81.1
35270,,,24959808,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '5.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5215527,"Antibacterial activity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as reduction in colony growth at 5 mg/ml,sc measured after 48 hrs",F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3898908,=,1,0,=,,Activity,log10CFU/ml,,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,,0.7
35271,,Toxic,24959817,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '5.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5215535,"Toxicity in ICR mouse infected with methicillin-resistant Staphylococcus aureus assessed as histopathological abnormalities in liver at 5 mg/kg,sc measured after 48 hrs by H and E staining based assay",T,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214897,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3898908,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
35272,,,24961346,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215881,Antibacterial activity against Acinetobacter baumannii ATCC 17978 assessed as inhIbition of bacterial growth incubated for 24 hrs by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.39
35273,,,24961347,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215882,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 24 hrs by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
35274,,,24961388,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215883,Antibacterial activity against Methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth incubated for 24 hrs by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
35275,,,24961409,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215884,Antibacterial activity against Methicillin-resistant Staphylococcus aureus NCTC10442 assessed as inhibition of bacterial growth incubated for 24 hrs by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
35276,,,24961430,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215885,Antibacterial activity Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated for 24 hrs by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.049
35277,,,24961451,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215886,Antibacterial activity Pseudomonas aeruginosa ATCC 9027 assessed as inhibition of bacterial growth incubated for 24 hrs by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
35278,,,24961472,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215887,Antibacterial activity against Acinetobacter baumannii R2889 assessed as inhIbition of bacterial growth incubated for 24 hrs by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.78
35279,,ND,24961493,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5215888,Hemolytic activity in rabbit RBC incubated for 1 hrs by fluorescence based microplate reader assay,T,,,BAO_0000179,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3899183,,1,0,,,HC50,,,,CHEMBL4296518,,Erythrocyte,,,,HC50,,,,
35280,,,24961506,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215889,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 24 hrs in the presence of 12.5 ug/mL Zn2+ by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
35281,,,24961519,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215890,Antibacterial activity against Methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth incubated for 24 hrs in the presence of 12.5 ug/mL Zn2+ by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
35282,,,24961532,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215891,Antibacterial activity against Methicillin-resistant Staphylococcus aureus NCTC10442 assessed as inhibition of bacterial growth incubated for 24 hrs in the presence of 12.5 ug/mL Zn2+ by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
35283,,,24961545,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215892,Antibacterial activity Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated for 24 hrs in the presence of 12.5 ug/mL Zn2+ by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.049
35284,,,24961558,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215893,Antibacterial activity Pseudomonas aeruginosa ATCC 9027 assessed as inhibition of bacterial growth incubated for 24 hrs in the presence of 12.5 ug/mL Zn2+ by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
35285,,,24961571,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215894,Antibacterial activity against Acinetobacter baumannii ATCC 17978 assessed as inhIbition of bacterial growth incubated for 24 hrs in the presence of 12.5 ug/mL Zn2+ by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.39
35286,,,24961584,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5215895,Antibacterial activity against Acinetobacter baumannii R2889 assessed as inhIbition of bacterial growth incubated for 24 hrs in the presence of 12.5 ug/mL Zn2+ by Muller hinton broth based dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899183,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.78
35287,,ND,24961597,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5215896,Hemolytic activity in rabbit RBC incubated for 1 hrs in the presence of 12.5 ug/mL Zn2+ by fluorescence based microplate reader assay,T,,,BAO_0000179,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3899183,,1,0,,,HC50,,,,CHEMBL4296518,,Erythrocyte,,,,HC50,,,,
35288,,,24962228,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5216114,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as bacterial growth inhibition measured after 5 days by MABA method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214920,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3899395,=,1,1,=,,MIC,nM,,3120.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,3.12
35289,,,24962264,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '5.0'}]",CHEMBL5216119,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 5 days by MABA method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214920,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899395,=,1,1,=,,MIC,ug.mL-1,,3.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,3.125
35290,,,24962328,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5216130,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition measured after 7 days by direct susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214920,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899395,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,3.12
35291,,,24962338,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5216131,Antitubercular activity against multi-drug-resistant Mycobacterium tuberculosis assessed as bacterial growth inhibition measured after 7 days by direct susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214920,Eur J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3899395,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,4.0
35292,,,24964416,[],CHEMBL5216815,Antibacterial activity against Escherichia coli ATCC6538 assessed as zone of inhibition by cup-plate agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214940,Bioorg Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3900136,=,1,1,=,,MIC,nM,,600.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.6
35293,,,24964437,[],CHEMBL5216816,Antibacterial activity against Klebsiella pneumoniae ATCC10031 assessed as zone of inhibition by cup-plate agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214940,Bioorg Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3900136,=,1,1,=,,MIC,nM,,1210.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,1.21
35294,,,24964458,[],CHEMBL5216817,Antibacterial activity against Pseudomonas aeruginosa ATCC27853 assessed as zone of inhibition by cup-plate agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214940,Bioorg Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3900136,=,1,1,=,,MIC,nM,,600.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,0.6
35295,,,24964479,[],CHEMBL5216818,Antibacterial activity against Staphylococcus aureus ATCC6538 assessed as zone of inhibition by cup-plate agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214940,Bioorg Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3900136,=,1,1,=,,MIC,nM,,7580.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,7.58
35296,,,24964486,[],CHEMBL5216819,Antibacterial activity against methicillin-resistant Staphylococcus aureus AUMC 261 assessed as zone of inhibition by cup-plate agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214940,Bioorg Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3900136,=,1,1,=,,MIC,nM,,570.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.57
35297,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24964489,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'min', 'standard_value': '15.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'min', 'value': '15.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'min', 'standard_value': '30.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'min', 'value': '30.0'}]",CHEMBL5216820,Inhibition of Escherichia coli DNA gyrase supercoiling activity using topoisomerase II treated decatenated kDNA as substrate incubated for 15 to 30 mins by agarose gel electrophoresis analysis,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214940,Bioorg Med Chem,2022.0,"{'bei': '18.65', 'le': '0.35', 'lle': '4.60', 'sei': '8.29'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.18,0,http://www.openphacts.org/units/Nanomolar,3900136,=,1,1,=,,IC50,nM,,661.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.6609999999999999
35298,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24964492,[],CHEMBL5216821,Inhibition of Escherichia coli topoisomerase 4 mediated relaxation of supercoiled pHOT1 DNA at expense of ATP hydrolysis by ethidium bromide staining based agarose gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5214940,Bioorg Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.09,0,http://www.openphacts.org/units/Nanomolar,3900136,=,1,1,=,,IC50,nM,,8159.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,8.158999999999999
35299,,,24983350,[],CHEMBL5226740,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
35300,,,24983354,[],CHEMBL5226741,Antibacterial activity against Pseudomonas aeruginosa No.010,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
35301,,,24983358,[],CHEMBL5226742,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa 025,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
35302,,,24983362,[],CHEMBL5226743,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa 034,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
35303,,,24983448,[],CHEMBL5226764,Antibacterial activity against Staphylococcus aureus by agar well diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
35304,,,24983452,[],CHEMBL5226765,Antibacterial activity against Bacillus subtilis by agar well diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,6.25
35305,,,24983456,[],CHEMBL5226766,Antibacterial activity against Escherichia coli by agar well diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.25
35306,,,24983466,[],CHEMBL5226767,Antibacterial activity against Staphylococcus aureus by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
35307,,,24983473,[],CHEMBL5226768,Antibacterial activity against Bacillus subtilis by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,50.0
35308,,,24983480,[],CHEMBL5226769,Antibacterial activity against Escherichia coli by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
35309,,,24983487,[],CHEMBL5226770,Antibacterial activity against Pseudomonas aeruginosa by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905358,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,25.0
35310,,,24988937,[],CHEMBL5229080,Bactericidal activity against Chlamydia trachomatis,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226349,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,3907332,>,1,0,>,,MBC,uM,,50.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,uM,UO_0000064,,50.0
35311,,,24989861,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5229449,Antibacterial activity against Bacillus cereus assessed as inhibition of bacterial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226364,J Nat Prod,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3907608,<,1,1,<,,MIC,nM,,400.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,uM,UO_0000065,,0.4
35312,,,24989877,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5229450,Antibacterial activity against Proteus sp. assessed as inhibition of bacterial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226364,J Nat Prod,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3907608,=,1,1,=,,MIC,nM,,800.0,CHEMBL613019,Proteus sp.,Proteus sp.,229037.0,,,MIC,uM,UO_0000065,,0.8
35313,,,24989893,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5229451,Antibacterial activity against Mycobacterium phlei assessed as inhibition of bacterial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226364,J Nat Prod,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3907608,<,1,1,<,,MIC,nM,,400.0,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,,MIC,uM,UO_0000065,,0.4
35314,,,24989909,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5229452,Antibacterial activity against Bacillus subtilis assessed as inhibition of bacterial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226364,J Nat Prod,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3907608,<,1,1,<,,MIC,nM,,400.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,uM,UO_0000065,,0.4
35315,,,24989925,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5229453,Antibacterial activity against Vibrio parahaemolyticus assessed as inhibition of bacterial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226364,J Nat Prod,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3907608,<,1,1,<,,MIC,nM,,400.0,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,,MIC,uM,UO_0000065,,0.4
35316,,,24989957,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5229455,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of bacterial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5226364,J Nat Prod,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3907608,>,1,1,>,,MIC,nM,,50000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,50.0
35317,,,24992454,[],CHEMBL5230362,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230084,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3908074,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
35318,,,24992469,[],CHEMBL5230362,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230084,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3908074,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
35319,,,24992533,[],CHEMBL5230390,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth by agar well diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230084,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3908074,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
35320,,,24992536,[],CHEMBL5230391,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230084,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3908074,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,20.0
35321,,,24996142,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5231788,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for 24 hrs by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,49.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,49.0
35322,,,24996158,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5231791,Antibacterial activity against Escherichia coli MTCC 443 assessed as inhibition of bacterial growth incubated for 18 to 20 hrs by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
35323,,,24996165,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5231792,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as inhibition of bacterial growth incubated for 18 to 20 hrs by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
35324,,,24996201,[],CHEMBL5231800,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth by broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
35325,,,24996207,[],CHEMBL5231801,Antibacterial activity against Bacillus subtilis assessed as inhibition of bacterial growth by broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.0
35326,,,24996216,[],CHEMBL5231804,Antibacterial activity against Bacillus subtilis assessed as inhibition of bacterial growth relative to control,F,,,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,3909556,=,1,1,=,,Inhibition,%,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,%,UO_0000187,,100.0
35327,,,24996221,[],CHEMBL5231805,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth relative to control,F,,,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,3909556,=,1,1,=,,Inhibition,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,INH,%,UO_0000187,,100.0
35328,,,24996235,[],CHEMBL5231809,Antibacterial activity against Bacillus flexus assessed as zone of inhibition,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,3909556,=,1,1,=,,IZ,mm,,0.75,CHEMBL5291654,Bacillus flexus,Bacillus flexus,86664.0,,,IZ,mm,UO_0000016,,0.75
35329,,,24996242,[],CHEMBL5231810,Antibacterial activity against Pseudomonas assessed as zone of inhibition,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,3909556,=,1,1,=,,IZ,mm,,0.75,CHEMBL612498,Pseudomonas,Pseudomonas,286.0,,,IZ,mm,UO_0000016,,0.75
35330,,,24996263,[],CHEMBL5231817,Antibacterial activity against Staphylococcus aureus MTCC 3160 assessed as inhibition of bacterial growth by broth micro dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.6
35331,,,24996266,[],CHEMBL5231818,Antibacterial activity against Pseudomonas aeruginosa MTCC 1034 assessed as inhibition of bacterial growth by broth micro dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.6
35332,,,24996268,[],CHEMBL5231819,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth by broth micro dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
35333,,,24996276,[],CHEMBL5231820,Antibacterial activity against Bacillus assessed as inhibition of bacterial growth by broth micro dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,,MIC,ug ml-1,UO_0000274,,2.0
35334,,,24996284,[],CHEMBL5231821,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth by broth micro dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
35335,,,24996327,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5231827,Antibacterial activity against Staphylococcus aureus ATCC-29213 assessed as inhibition of bacterial growth incubated for 16 hrs by agar-well diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909556,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,10.0
35336,,,24997421,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '100.0'}]",CHEMBL5232023,Antibacterial activity against Salmonella typhimurium DT104 assessed as zone of inhibition at 100 ug/ml,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230136,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909844,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,5.0
35337,,,25000125,[],CHEMBL5232836,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230163,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3910945,=,1,1,=,,MIC,nM,,1270.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,1.27
35338,,,25000145,[],CHEMBL5232837,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230163,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3910945,=,1,1,=,,MIC,nM,,10100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,10.1
35339,,,25000165,[],CHEMBL5232838,Antibacterial activity against Salmonella ATCC 12022 assessed as inhibition of bacterial growth by standard broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230163,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3910945,=,1,1,=,,MIC,nM,,2540.0,CHEMBL614446,Salmonella,Salmonella,590.0,,,MIC,uM,UO_0000065,,2.54
35340,,,25000337,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232878,Antibacterial activity against methicillin sensitive Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911003,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
35341,,,25000367,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232879,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911003,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
35342,,,25000397,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232880,Antibacterial activity against clinical isolate methicillin resistant Staphylococcus epidermidis AB 735 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911003,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
35343,,,25000427,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232881,Antibacterial activity against vancomycin resistant Enterococcus faecalis ATCC 700802 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911003,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
35344,,,25000457,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232882,Antibacterial activity against Enterococcus faecium ATCC 49624 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911003,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
35345,,,25000487,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232883,Antibacterial activity against clinical isolate Escherichia coli AB 117 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911003,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
35346,,,25000517,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232884,Antibacterial activity against clinical isolate Klebsiella pneumoniae AB 356 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911003,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.125
35347,,,25000547,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232885,Antibacterial activity against clinical isolate Pseudomonas aeruginosa AB 645 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911003,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
35348,,,25000577,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232886,Antibacterial activity against clinical isolate Acinetobacter baumannii BAA 747 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911003,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
35349,,,25000607,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '22.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '22.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5232887,Antibacterial activity against Moraxella catarrhalis ATCC 25238 assessed as inhibition of bacterial growth incubated for 22 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911003,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.03
35350,,,25002977,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233660,Anticancer activity against human SK-MEL3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,>,1,1,>,,IC50,nM,,128000.0,CHEMBL614920,Homo sapiens,SK-MEL3,9606.0,,,IC50,uM,UO_0000065,,128.0
35351,,,25002991,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233661,Anticancer activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,>,1,1,>,,IC50,nM,,128000.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,IC50,uM,UO_0000065,,128.0
35352,,,25003005,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233662,Anticancer activity against human A-431 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,>,1,1,>,,IC50,nM,,128000.0,CHEMBL614069,Homo sapiens,A-431,9606.0,,,IC50,uM,UO_0000065,,128.0
35353,,,25003019,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233663,Anticancer activity against human EJ cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,>,1,1,>,,IC50,nM,,128000.0,CHEMBL614292,Homo sapiens,EJ,9606.0,,,IC50,uM,UO_0000065,,128.0
35354,,,25003033,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233664,Anticancer activity against human KB cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,>,1,1,>,,IC50,nM,,128000.0,CHEMBL398,Homo sapiens,KB,9606.0,,,IC50,uM,UO_0000065,,128.0
35355,,,25003047,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233665,Anticancer activity against human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,>,1,1,>,,IC50,nM,,128000.0,CHEMBL612544,Homo sapiens,SW480,9606.0,,,IC50,uM,UO_0000065,,128.0
35356,,,25003062,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5233667,Antitumor activity against mouse CT26 cells assessed as reduction in cell viability incubated for 4 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,=,1,1,=,,IC50,nM,,330000.0,CHEMBL613866,Mus musculus,CT26,10090.0,,,IC50,mM,UO_0000065,,0.33
35357,,,25003072,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5233668,Antitumor activity against human A549 cells assessed as reduction in cell viability incubated for 4 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,=,1,1,=,,IC50,nM,,330000.0,CHEMBL392,Homo sapiens,A549,9606.0,,,IC50,mM,UO_0000065,,0.33
35358,,,25003093,[],CHEMBL5233677,Cytotoxicity against Chinese hamster CHO cells assessed as reduction in cell viability by MTT assay,T,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,>,1,1,>,,IC50,nM,,150000.0,CHEMBL613853,Cricetulus griseus,CHO,10029.0,,,IC50,uM,UO_0000065,,150.0
35359,,,25003104,[],CHEMBL5233678,Cytotoxicity against human HL-60 cells assessed as reduction in cell viability by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,>,1,1,>,,IC50,nM,,150000.0,CHEMBL383,Homo sapiens,HL-60,9606.0,,,IC50,uM,UO_0000065,,150.0
35360,,,25003115,[],CHEMBL5233679,Cytotoxicity against mouse L1210 cells assessed as reduction in cell viability by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,>,1,1,>,,IC50,nM,,150000.0,CHEMBL386,Mus musculus,L1210,10090.0,,,IC50,uM,UO_0000065,,150.0
35361,,,25003204,[],CHEMBL5233720,Antiproliferative activity against mouse L1210 cells assessed as reduction in cell viability by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3911708,>,1,1,>,,IC50,nM,,150000.0,CHEMBL386,Mus musculus,L1210,10090.0,,,IC50,uM,UO_0000065,,150.0
35362,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25005070,[],CHEMBL5234498,Inhibition of Salmonella typhimurium DNA gyrase,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
35363,,,25005072,[],CHEMBL5234499,Antibacterial activity against Salmonella typhimurium assessed as inhibition was bacterial growth by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.016
35364,,,25005074,[],CHEMBL5234500,Antibacterial activity against Salmonella enterica assessed as inhibition was bacterial growth by broth micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,,MIC,ug ml-1,UO_0000274,,0.016
35365,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25005082,[],CHEMBL5234501,Inhibition of Escherichia coli DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,IC50,ug.mL-1,,0.77,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,0.77
35366,,,25005124,[],CHEMBL5234516,Anti-tubercular activity against Mycobacterium tuberculosis H37Rv strain,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3912692,=,1,1,=,,MIC,nM,,12500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,12.5
35367,,,25005140,[],CHEMBL5234519,Antibacterial activity against methicillin-sensitive Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
35368,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25005146,[],CHEMBL5234520,Inhibition of Staphylococcus aureus DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,IC50,ug.mL-1,,3.55,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,ug ml-1,UO_0000274,,3.55
35369,,,25005150,[],CHEMBL5234521,Antibacterial activity against healthcare-acquired methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
35370,,,25005151,[],CHEMBL5234522,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.3
35371,,,25005154,[],CHEMBL5234523,Antibacterial activity against Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.79,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.79
35372,,,25005159,[],CHEMBL5234524,Antibacterial activity against Streptococcus pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.39
35373,,,25005162,[],CHEMBL5234525,Antibacterial activity against Acinetobacter baumannii,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.78
35374,,,25005171,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5234532,Antimicrobial activity against Staphylococcus aureus assessed as inhibition of visible growth incubated for 24 hrs by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
35375,,,25005173,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5234533,Antimicrobial activity against Listeria monocytogenes assessed as inhibition of visible growth incubated for 24 hrs by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,0.125
35376,,,25005175,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5234534,Antimicrobial activity against Escherichia coli assessed as inhibition of visible growth incubated for 24 hrs by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
35377,,,25005177,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5234535,Antimicrobial activity against Salmonella gallinarum assessed as inhibition of visible growth incubated for 24 hrs by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612604,Salmonella enterica subsp. enterica serovar Gallinarum,Salmonella enterica subsp. enterica serovar Gallinarum,594.0,,,MIC,ug ml-1,UO_0000274,,0.125
35378,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25005196,[],CHEMBL5234550,Inhibition of Staphylococcus aureus DNA gyrase assessed as relaxation of pBR322 DNA by supercoiling assay,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912692,=,1,1,=,,IC50,ug.mL-1,,2.85,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,ug ml-1,UO_0000274,,2.85
35379,,,25009100,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5236017,Antibacterial activity against Bacillus subtilis assessed as inhibition of bacterial growth measured per 100 uL incubated for 24 hrs by agar well diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233274,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3914154,=,1,0,=,,MIC,ug,,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug,UO_0000023,,6.25
35380,,,25009110,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5236018,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth measured per 100 uL incubated for 24 hrs by agar well diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5233274,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3914154,=,1,0,=,,MIC,ug,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug,UO_0000023,,6.25
35381,,,25019165,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5238975,Bactericidal activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 after 24 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916296,=,1,0,=,,MBC,ug ml-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,32.0
35382,,,25019174,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5238976,Bactericidal activity against Klebsiella pneumoniae ATCC BAA-1705 after 24 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916296,=,1,0,=,,MBC,ug ml-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MBC,ug ml-1,UO_0000274,,16.0
35383,,,25019183,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5238977,Bactericidal activity against Pseudomonas aeruginosa ATCC 27883 after 24 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916296,=,1,0,=,,MBC,ug ml-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,8.0
35384,,,25019192,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5238978,Bactericidal activity against Escherichia coli ATCC 25992 after 24 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916296,=,1,0,=,,MBC,ug ml-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,16.0
35385,,,25019285,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5239023,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 incubated for 24 hrs by checkerboard assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916296,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
35386,,,25019296,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5239024,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 incubated for 24 hrs by checkerboard assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916296,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
35387,,,25019307,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5239025,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by checkerboard assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916296,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
35388,,,25019318,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5239026,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1705 incubated for 24 hrs by checkerboard assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916296,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,256.0
35389,,Active,25019542,[],CHEMBL5239146,Induction of resistance development in Staphylococcus aureus ATCC 29213 assessed as increase in MIC by microtiter plate reader assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3916296,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35390,,Active,25019546,[],CHEMBL5239147,Induction of resistance development in methicillin resistant Staphylococcus aureus ATCC BAA-1556 assessed as increase in MIC by microtiter plate reader assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3916296,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35391,,Active,25019550,[],CHEMBL5239148,Induction of resistance development in Escherichia coli ATCC 25922 assessed as increase in MIC by microtiter plate reader assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3916296,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
35392,,Active,25019554,[],CHEMBL5239149,Induction of resistance development in Escherichia coli ATCC BAA-2452 assessed as increase in MIC by microtiter plate reader assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3916296,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
35393,,,25029819,[],CHEMBL5241299,Antimicrobial activity against Methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918667,=,1,0,=,,MBC,ug ml-1,,625.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,625.0
35394,,,25029892,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5241319,Antimicrobial activity against Escherichia coli ATCC 8739 assessed as bacterial growth inhibition incubated for 18 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918667,>,1,1,>,,MIC,ug.mL-1,,1.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.8
35395,,,25029898,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5241320,Antimicrobial activity against Salmonella typhimurium ATCC 25922 assessed as bacterial growth inhibition incubated for 18 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918667,>,1,1,>,,MIC,ug.mL-1,,1.8,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,1.8
35396,,,25029904,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5241321,Antimicrobial activity against Klebsiella pneumoniae ATCC 314588 assessed as bacterial growth inhibition incubated for 18 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918667,>,1,1,>,,MIC,ug.mL-1,,1.8,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.8
35397,,,25029910,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5241322,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition incubated for 18 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918667,>,1,1,>,,MIC,ug.mL-1,,1.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.8
35398,,,25029916,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5241323,Antimicrobial activity against Methicillin-resistant Staphylococcus aureus ATCC BAA 1683 assessed as bacterial growth inhibition incubated for 18 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918667,=,1,1,=,,MIC,ug.mL-1,,1.84,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.84
35399,,,25029951,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '24.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5241337,Antimicrobial activity against Staphylococcus aureus MTCC 96 assessed as bacterial growth inhibition incubated for 24 to 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918667,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
35400,,,25029953,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '24.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5241338,Antimicrobial activity against Staphylococcus aureus MTCC 442 assessed as bacterial growth inhibition incubated for 24 to 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918667,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
35401,,,25029960,[],CHEMBL5241340,Antimicrobial activity against Methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as bacterial growth inhibition by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918667,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
35402,,,25029968,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5241341,Antimicrobial activity against Methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition incubated for 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918667,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
35403,,,25030543,[],CHEMBL5241573,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as inhibition zone by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241069,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,3919027,=,1,1,=,,IZ,mm,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,22.0
35404,,,25030556,[],CHEMBL5241574,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as inhibition of bacterial growth by broth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241069,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919027,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
35405,,,25030557,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '24.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5241575,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth incubated for 24 to 48 hrs by spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241069,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919027,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
35406,,,25030581,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5241581,Antibacterial activity against methicillin resistant Staphylococcus aureus MTCC 84 incubated for 24 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241069,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919027,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
35407,,,25030627,[],CHEMBL5241623,Antibacterial activity against methicillin resistant Staphylococcus aureus 032 assessed as inhibition of bacterial growth by CLSI protocol based serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241069,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919027,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
35408,,,25032515,[],CHEMBL5242327,Antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
35409,,,25032587,[],CHEMBL5242329,Antibacterial activity against Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.15
35410,,,25032620,[],CHEMBL5242330,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.012
35411,,,25032670,[],CHEMBL5242331,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.015
35412,,,25032715,[],CHEMBL5242332,Antibacterial activity against methicillin resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.98,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.98
35413,,,25032823,[],CHEMBL5242337,Antibacterial activity against Micrococcus luteus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,7.8,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,7.8
35414,,,25032838,[],CHEMBL5242338,Antibacterial activity against Staphylococcus epidermidis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.015
35415,,,25032847,[],CHEMBL5242339,Antibacterial activity against Bacillus subtilis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.015
35416,,,25032863,[],CHEMBL5242341,Antibacterial activity against quinolone susceptible Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.008
35417,,,25032867,[],CHEMBL5242342,Antibacterial activity against quinolone susceptible Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
35418,,,25032870,[],CHEMBL5242343,Antibacterial activity against quinolone resistant Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
35419,,,25032873,[],CHEMBL5242344,Antibacterial activity against quinolone resistant Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
35420,,,25032877,[],CHEMBL5242345,Antibacterial activity against quinolone resistant Acinetobacter baumannii,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
35421,,,25032889,[],CHEMBL5242351,Antibacterial activity against Bacillus megaterium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,7.8,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,7.8
35422,,,25032899,[],CHEMBL5242352,Antibacterial activity against Salmonella typhi,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,0.15
35423,,,25032943,[],CHEMBL5242360,Antibacterial activity against methicillin susceptible Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.195
35424,,,25032955,[],CHEMBL5242368,Antibacterial activity against Clostridioides difficile,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,ug ml-1,UO_0000274,,32.0
35425,,,25032956,[],CHEMBL5242368,Antibacterial activity against Clostridioides difficile,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC90,ug.mL-1,,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,ug ml-1,UO_0000274,,128.0
35426,,,25032963,[],CHEMBL5242369,Antibacterial activity against ciprofloxacin resistant Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,20.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,20.5
35427,,,25032965,[],CHEMBL5242370,Antibacterial activity against ciprofloxacin resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,20.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,20.5
35428,,,25032970,[],CHEMBL5242372,Antibacterial activity against Chlamydia trachomatis,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,>,1,0,>,,MBC,ug ml-1,,50.0,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,50.0
35429,,,25032978,[],CHEMBL5242376,Antibacterial activity against Vibrio cholerae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,0.15
35430,,,25032981,[],CHEMBL5242377,Antibacterial activity against Shigella flexneri,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,,MIC,ug ml-1,UO_0000274,,0.15
35431,,,25032984,[],CHEMBL5242378,Antibacterial activity against Citrobacter freundii,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.15
35432,,,25032986,[],CHEMBL5242379,Antibacterial activity against Escherichia coli UTI89,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
35433,,,25032988,[],CHEMBL5242380,Antibacterial activity against Escherichia coli CFT073,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919803,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
35434,,,25035591,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5243163,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition incubated for 24 hrs by MABA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3920835,=,1,1,=,,MIC,ug.mL-1,,3.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,3.125
35435,,,25035721,[],CHEMBL5243206,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3920835,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
35436,,,25035723,[],CHEMBL5243207,Antibacterial activity against Bacillus subtilis assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3920835,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,50.0
35437,,,25035782,[],CHEMBL5243225,Antibacterial activity against Salmonella typhimurium MTCC 98 assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3920835,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,25.0
35438,,,25035826,[],CHEMBL5243235,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3920835,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.12
35439,,,25035835,[],CHEMBL5243236,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3920835,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,3.12
35440,,,25035844,[],CHEMBL5243237,Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3920835,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,3.12
35441,,,25035853,[],CHEMBL5243238,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3920835,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.12
35442,,,25040066,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244529,Antimalarial activity against hepatic stage Plasmodium yoelii yoelii 265 BY for 48 hrs with media renew every 24 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922421,=,1,1,=,,IC50,ug.mL-1,,44.0,CHEMBL612328,Plasmodium yoelii yoelii,Plasmodium yoelii yoelii,73239.0,,,IC50,ug ml-1,UO_0000274,,44.0
35443,,,25040090,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244530,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum NF54-R infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922421,=,1,1,=,,IC50,ug.mL-1,,3.4,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,3.4
35444,,,25040116,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244531,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922421,=,1,1,=,,IC50,ug.mL-1,,9.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,9.2
35445,,,25040141,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244532,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCC1 measured after 48 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3922421,=,1,1,=,,IC50,nM,,260000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,260.0
35446,,,25040147,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244533,Antimalarial activity against chloroquine-resistant Plasmodium falciparum VNS measured after 48 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3922421,=,1,1,=,,IC50,nM,,380000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,380.0
35447,,,25040153,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244534,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum FC measured after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922421,=,1,1,=,,MIC,ug.mL-1,,28.1,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,MIC,ug ml-1,UO_0000274,,28.1
35448,,,25040154,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244535,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 measured after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922421,=,1,1,=,,MIC,ug.mL-1,,27.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,MIC,ug ml-1,UO_0000274,,27.2
35449,,,25040155,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244536,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum FC measured after 96 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922421,=,1,1,=,,MIC,ug.mL-1,,2.8,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,MIC,ug ml-1,UO_0000274,,2.8
35450,,,25040156,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244537,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum K1 measured after 96 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922421,=,1,1,=,,MIC,ug.mL-1,,4.4,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,MIC,ug ml-1,UO_0000274,,4.4
35451,,,25040157,[],CHEMBL5244538,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922421,=,1,1,=,,IC50,ug.mL-1,,6.38,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,6.38
35452,,,25040160,[],CHEMBL5244539,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922421,=,1,1,=,,IC50,ug.mL-1,,6.38,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,6.38
35453,,,25040173,[],CHEMBL5244545,Antiplasmodial activity against synchronized Plasmodium falciparum CS2,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.7,0,http://www.openphacts.org/units/Nanomolar,3922421,=,1,1,=,,IC50,nM,,20000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,20.0
35454,,,25040176,[],CHEMBL5244546,Antiplasmodial activity against asynchronous Plasmodium falciparum CS2,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.62,0,http://www.openphacts.org/units/Nanomolar,3922421,=,1,1,=,,IC50,nM,,24000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,24.0
35455,,,25040179,[],CHEMBL5244547,Antiplasmodial activity against synchronized Plasmodium falciparum 3D7,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.51,0,http://www.openphacts.org/units/Nanomolar,3922421,=,1,1,=,,IC50,nM,,31000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,31.0
35456,,,25040182,[],CHEMBL5244548,Antiplasmodial activity against asynchronous Plasmodium falciparum 3D7,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.51,0,http://www.openphacts.org/units/Nanomolar,3922421,=,1,1,=,,IC50,nM,,31000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,31.0
35457,,,25040185,[],CHEMBL5244549,Antiplasmodial activity against synchronized Plasmodium falciparum K1,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.5,0,http://www.openphacts.org/units/Nanomolar,3922421,=,1,1,=,,IC50,nM,,32000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,32.0
35458,,,25040188,[],CHEMBL5244550,Antiplasmodial activity against asynchronous Plasmodium falciparum K1,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.42,0,http://www.openphacts.org/units/Nanomolar,3922421,=,1,1,=,,IC50,nM,,38000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,38.0
35459,,,25040608,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '800.0'}]",CHEMBL5244742,Antibacterial activity against Bacillus subtilis MTCC 121 assessed as zone of inhibition at 800 ug/mL by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244216,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,3922706,=,1,1,=,,IZ,mm,,18.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,18.0
35460,,,25040611,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '800.0'}]",CHEMBL5244743,Antibacterial activity against Staphylococcus aureus 22 assessed as zone of inhibition at 800 ug/mL by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244216,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,3922706,=,1,1,=,,IZ,mm,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,20.0
35461,,,25040614,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '800.0'}]",CHEMBL5244744,Antibacterial activity against Escherichia coli K12 assessed as zone of inhibition at 800 ug/mL by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244216,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,3922706,=,1,1,=,,IZ,mm,,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,21.0
35462,,,25040617,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '800.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '800.0'}]",CHEMBL5244745,Antibacterial activity against Klebsiella pneumoniae assessed as zone of inhibition at 800 ug/mL by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244216,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,3922706,=,1,1,=,,IZ,mm,,23.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,mm,UO_0000016,,23.0
35463,,,25040706,[],CHEMBL5244788,Antimicrobial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922852,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
35464,,,25040726,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244791,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Alamar blue staining based analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922852,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
35465,,,25040758,[],CHEMBL5244794,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 by two fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3922852,=,1,1,=,,MIC,nM,,8.79,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,nM,UO_0000065,,8.79
35466,,,25040780,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244798,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 1 measured after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922852,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
35467,,,25040785,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244799,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 measured after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922852,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
35468,,,25040800,[],CHEMBL5244804,Antimicrobial activity against methicillin-resistant Staphylococcus aureus Mi300 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922852,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
35469,,,25040803,[],CHEMBL5244805,Antimicrobial activity against methicillin-resistant Staphylococcus aureus Mi339 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922852,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
35470,,,25040824,[],CHEMBL5244807,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922852,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
35471,,,25040832,[],CHEMBL5244807,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922852,<,1,1,<,,MIC,ug.mL-1,,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.016
35472,,,25040840,[],CHEMBL5244808,Bactericidal activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of microbial growth,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922852,=,1,0,=,,MBC,ug ml-1,,0.031,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.031
35473,,,25040858,[],CHEMBL5244811,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922852,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
35474,,,25040888,[],CHEMBL5244822,Antibacterial activity against Escherichia coli ATCC 8739 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
35475,,,25040891,[],CHEMBL5244823,Antibacterial activity against Escherichia coli ISF 432 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
35476,,,25040896,[],CHEMBL5244824,Antibacterial activity against Escherichia coli ATCC 700603 assessed as bacterial growth inhibition by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
35477,,,25040942,[],CHEMBL5244826,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
35478,,,25040948,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL5244828,Antibacterial activity against Escherichia coli KC-14 infected in po dosed mouse assessed as bacterial growth inhibition,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3922896,=,1,1,=,,ED50,mg.kg-1,,0.45,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,0.45
35479,,,25041027,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244839,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition measured after 18 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
35480,,,25041062,[],CHEMBL5244842,Antibacterial activity against Escherichia coli TolC assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,8.21,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.21
35481,,,25041091,[],CHEMBL5244852,Antibacterial activity against Escherichia coli NIHJ JC-2 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,0.0063,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0063
35482,,,25041135,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244855,Antibacterial activity against Escherichia coli 2010-05 assessed as bacterial growth inhibition measured after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
35483,,,25041145,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244856,Antibacterial activity against Escherichia coli 2010-29 assessed as bacterial growth inhibition measured after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
35484,,,25041160,[],CHEMBL5244865,Antibacterial activity against Escherichia coli NCTC 10419 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,0.0011,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0011
35485,,,25041164,[],CHEMBL5244867,Antibacterial activity against Escherichia coli JM109 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
35486,,,25041176,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244872,Antibacterial activity against Escherichia coli ATCC 8739 assessed as bacterial growth inhibition incubated for 24 hrs by two-serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
35487,,,25041188,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244873,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.78
35488,,,25041204,[],CHEMBL5244874,Antibacterial activity against Escherichia coli NCDC 134 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,40.0
35489,,,25041247,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244875,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 18 hrs by twofold serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
35490,,,25041265,[],CHEMBL5244876,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
35491,,,25041267,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5244878,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
35492,,,25041275,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL5244879,Invivo antibacterial activity against Escherichia coli NCTC 10419 infected in po dosed CF-mouse assessed as bacterial growth inhibition,F,,,BAO_0000188,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3922896,=,1,0,=,,EC50,mg kg-1,,1.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,EC50,mg kg-1,UO_0000308,,1.25
35493,,,25041309,[],CHEMBL5244890,Antibacterial activity against Escherichia coli H560 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,<=,1,1,<=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
35494,,,25041313,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL5244891,Invivo antibacterial activity against Escherichia coli H560 infected in po dosed CD-1 mouse assessed as bacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3922896,=,1,0,=,,PD50,mg kg-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.0
35495,,,25041315,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SC', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SC', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL5244892,Invivo antibacterial activity against Escherichia coli H560 infected in sc dosed CD-1 mouse assessed as bacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3922896,=,1,0,=,,PD50,mg kg-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.3
35496,,,25041320,[],CHEMBL5244893,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,4.0
35497,,,25041324,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244894,Antibacterial activity against clinical isolate Escherichia coli assessed as bacterial growth inhibition incubated for 24 hrs by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922896,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
35498,,,25042311,[],CHEMBL5245036,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as inhibition of bacterial growth by agar well diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244223,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3923611,=,1,1,=,,MIC,ug.mL-1,,18.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,18.75
35499,,,25042326,[],CHEMBL5245037,Antibacterial activity against Staphylococcus epidermidis MTCC 435 assessed as inhibition of bacterial growth by agar well diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244223,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3923611,=,1,1,=,,MIC,ug.mL-1,,18.75,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,18.75
35500,,,25042341,[],CHEMBL5245038,Antibacterial activity against Escherichia coli MTCC 443 assessed as inhibition of bacterial growth by agar well diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244223,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3923611,=,1,1,=,,MIC,ug.mL-1,,18.75,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,18.75
35501,,,25042356,[],CHEMBL5245039,Antibacterial activity against Pseudomonas aeruginosa MTCC 741 assessed as inhibition of bacterial growth by agar well diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244223,Eur J Med Chem,2018.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3923611,=,1,1,=,,MIC,ug.mL-1,,18.75,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,18.75
35502,,,25048911,[],CHEMBL5246869,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,3.12
35503,,,25049043,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5246885,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 5 days by alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,3.12
35504,,,25049585,[],CHEMBL5246928,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth by alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,3.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,3.125
35505,,,25049787,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'TIME', 'units': 'weeks', 'value': '2.0'}]",CHEMBL5246949,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 2 weeks,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35506,,,25049810,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '504.0', 'text_value': None, 'type': 'TIME', 'units': 'weeks', 'value': '3.0'}]",CHEMBL5246950,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 3 weeks,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35507,,,25049833,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '672.0', 'text_value': None, 'type': 'TIME', 'units': 'weeks', 'value': '4.0'}]",CHEMBL5246951,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 4 weeks,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35508,,,25049856,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '840.0', 'text_value': None, 'type': 'TIME', 'units': 'weeks', 'value': '5.0'}]",CHEMBL5246952,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 5 weeks,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35509,,,25049879,[],CHEMBL5246953,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 199-00 harboring gyrA QRDR c270t (A90V) mutant and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,32.0
35510,,,25049882,[],CHEMBL5246954,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 581-17 harboring gyrA QRDR c270t (A90V) mutant and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,2.0
35511,,,25049885,[],CHEMBL5246955,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 410-11 harboring wild type and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,8.0
35512,,,25049888,[],CHEMBL5246956,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 742-0 harboring gyrA QRDR a282g (D94G) mutant and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,8.0
35513,,,25049891,[],CHEMBL5246957,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 666-0 harboring wild type gyrA and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,8.0
35514,,,25049894,[],CHEMBL5246958,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 383-0 harboring wild type gyrA and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,8.0
35515,,,25049897,[],CHEMBL5246959,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 152-0 harboring wild type gyrA and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,8.0
35516,,,25049900,[],CHEMBL5246960,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 427-18 harboring gyrA QRDR c270t (A90V) mutant and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,4.0
35517,,,25049903,[],CHEMBL5246961,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 775-0 harboring gyrA QRDR c270t (A90V) mutant and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,4.0
35518,,,25049906,[],CHEMBL5246962,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate 124-0 harboring wild type gyrA and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
35519,,,25049909,[],CHEMBL5246963,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harboring wild type gyrA and wild type gyrB,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925591,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
35520,,,25072361,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '3.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '3.0'}]",CHEMBL5253335,Bactericidal activity against Staphylococcus aureus assessed as log reduction in bacterial count at 4 times MIC and measured after 3 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5252521,Bioorg Med Chem,2016.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3929954,=,1,0,=,,Activity,log10CFU,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU,,,3.0
35521,,,25090172,[],CHEMBL5257864,Antibacterial activity against Mycobacterium tuberculosis H37Rv by alamar blue method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257034,Eur J Med Chem,2016.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3933630,=,1,1,=,,MIC,ug.mL-1,,4.7,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,4.7
35522,,,25094916,[],CHEMBL5259750,Antibacterial activity against Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257105,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3934862,<,1,1,<,,MIC,nM,,900.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.9
35523,,,25094935,[],CHEMBL5259754,Antibacterial activity against Staphylococcus aureus ATCC 215,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257105,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3934862,>,1,1,>,,MIC,nM,,50000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,50.0
35524,,,25094939,[],CHEMBL5259755,Antibacterial activity against Staphylococcus aureus ATCC 216,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257105,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3934862,=,1,1,=,,MIC,nM,,22200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,22.2
35525,,,25094943,[],CHEMBL5259756,Antibacterial activity against Staphylococcus aureus ATCC 217,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257105,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3934862,>,1,1,>,,MIC,nM,,50000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,50.0
35526,,,25094947,[],CHEMBL5259757,Antibacterial activity against Staphylococcus aureus ATCC 219,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257105,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3934862,=,1,1,=,,MIC,nM,,22200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,22.2
35527,,,25094951,[],CHEMBL5259758,Antibacterial activity against Staphylococcus aureus ATCC 223,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257105,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3934862,=,1,1,=,,MIC,nM,,22200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,22.2
35528,,,25094955,[],CHEMBL5259759,Antibacterial activity against Staphylococcus aureus ATCC 701,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257105,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3934862,>,1,1,>,,MIC,nM,,50000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,50.0
35529,,,25094959,[],CHEMBL5259760,Antibacterial activity against Staphylococcus aureus ATCC 711,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257105,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3934862,>,1,1,>,,MIC,nM,,50000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,50.0
35530,,,25094963,[],CHEMBL5259761,Antibacterial activity against Staphylococcus aureus ATCC 716,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257105,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3934862,=,1,1,=,,MIC,nM,,14800.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,14.8
35531,,,25095638,[],CHEMBL5259975,Antibacterial activity against multidrug resistant Escherichia coli ATCC 25922 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257115,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935076,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
35532,,,25095651,[],CHEMBL5259976,Antibacterial activity against multidrug resistant Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257115,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935076,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
35533,,,25095664,[],CHEMBL5259977,Antibacterial activity against multidrug resistant Staphylococcus aureus ATCC 43300 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257115,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935076,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
35534,,,25095677,[],CHEMBL5259978,Antibacterial activity against multidrug resistant Escherichia coli ATCC 2774 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257115,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935076,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
35535,,,25095690,[],CHEMBL5259979,Antibacterial activity against multidrug resistant Klebsiella pneumoniae ATCC 2782 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257115,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935076,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,128.0
35536,,,25095703,[],CHEMBL5259980,Antibacterial activity against multidrug resistant Klebsiella pneumoniae ATCC 2146 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257115,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935076,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,128.0
35537,,,25095716,[],CHEMBL5259981,Antibacterial activity against multidrug resistant Acinetobacter baumannii ATCC 2803 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257115,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935076,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
35538,,,25096427,[],CHEMBL5260142,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 33591 assessed as reduction in bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935327,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
35539,,,25096451,[],CHEMBL5260143,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935327,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
35540,,,25096497,[],CHEMBL5260145,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935327,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
35541,,,25096548,[],CHEMBL5260148,Bactericidal activity against methicillin resistant Staphylococcus aureus ATCC 33591 assessed as reduction in bacterial growth,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935327,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.0
35542,,,25096557,[],CHEMBL5260149,Bactericidal activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial growth,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935327,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
35543,,,25096565,[],CHEMBL5260150,Bactericidal activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3935327,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,1.0
35544,,Active,25096569,[],CHEMBL5260151,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as reduction in bacterial growth at 1 times MIC by time kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3935327,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35545,,Active,25096575,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5260154,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as reduction in bacterial growth at 8 times MIC measured at 24 hrs by time kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,3935327,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
35546,,,25096577,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '12.0'}]",CHEMBL5260155,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as reduction in bacterial growth at 8 times MIC measured at 12 hrs by time kill assay,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,3935327,=,1,0,=,,Activity,%,,99.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,99.9
35547,,,25096584,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '1.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5260158,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as reduction in bacterial growth at 1 microg/ml measured for 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,3935327,=,1,0,=,,PAE,hr,,1.22,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.22
35548,,,25096586,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '2.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5260159,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as reduction in bacterial growth at 2 microg/ml measured for 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5257124,Bioorg Med Chem Lett,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,3935327,=,1,0,=,,PAE,hr,,1.58,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.58
35549,,,25100706,[],CHEMBL5261342,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260805,Eur J Med Chem,2017.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936325,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
35550,,,25100709,[],CHEMBL5261343,Antibacterial activity against Bacillus subtilis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260805,Eur J Med Chem,2017.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936325,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.78
35551,,,25100713,[],CHEMBL5261344,Antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260805,Eur J Med Chem,2017.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936325,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.78
35552,,,25100718,[],CHEMBL5261345,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260805,Eur J Med Chem,2017.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936325,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
35553,,,25100720,[],CHEMBL5261346,Antibacterial activity against Salmonella typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260805,Eur J Med Chem,2017.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936325,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.78
35554,,,25100722,[],CHEMBL5261347,Antibacterial activity against Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260805,Eur J Med Chem,2017.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936325,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.78
35555,,,25103811,[],CHEMBL5262789,Antimycobacterial activity against Mycobacterium tuberculosis Rv0005 harbouring gyrB gene,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260811,Eur J Med Chem,2017.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936462,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.125
35556,,,25103816,[],CHEMBL5262790,Antimycobacterial activity against Mycobacterium tuberculosis Rv0006 harbouring gyrA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260811,Eur J Med Chem,2017.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936462,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.125
35557,,,25110966,[],CHEMBL5265143,Antimicrobial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,7.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,7.0
35558,,,25110970,[],CHEMBL5265145,Antimicrobial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,18.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,18.0
35559,,,25111117,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '120.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '5.0'}]",CHEMBL5265177,Antitubercular activity against Mycobacterium tuberculosis measured after 5 days by alamar blue dye based analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,3.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,3.125
35560,,,25111136,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5265181,Antibacterial activity against Staphylococcus aureus incubated for 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,10.0
35561,,,25111152,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5265182,Antibacterial activity against Bacillus subtilis incubated for 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,10.0
35562,,,25111168,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5265183,Antibacterial activity against Pseudomonas aeruginosa incubated for 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,10.0
35563,,,25111184,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5265184,Antibacterial activity against Escherichia coli incubated for 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
35564,,,25111200,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5265185,Antifungal activity against Aspergillus fumigatus incubated for 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MIC,ug ml-1,UO_0000274,,10.0
35565,,,25111216,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5265186,Antifungal activity against Aspergillus niger incubated for 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,,MIC,ug ml-1,UO_0000274,,10.0
35566,,,25111232,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5265187,Antifungal activity against Candida albicans incubated for 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,10.0
35567,,,25111248,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5265188,Antifungal activity against Aspergillus flavus incubated for 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,,MIC,ug ml-1,UO_0000274,,10.0
35568,,,25111255,[],CHEMBL5265191,Antimicrobial activity against Staphylococcus aureus assessed as inhibition of microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,<,1,1,<,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
35569,,,25111259,[],CHEMBL5265192,Antimicrobial activity against Candida albicans assessed as inhibition of microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5260848,Eur J Med Chem,2020.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3939139,<,1,1,<,,MIC,ug.mL-1,,5.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,5.0
35570,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25114363,[],CHEMBL5291811,Binding affinity towards human HRH2 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35571,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25114647,[],CHEMBL5291902,Binding affinity towards human DRD1 in an in vitro assay with cellular components (NIBR assay) measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35572,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25115060,[],CHEMBL5291779,Binding affinity towards human DRD1 in an in vitro assay with cellular components (NIBR assay) measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35573,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25116741,[],CHEMBL5291774,"Compound was evaluated for inhibition of human CNR1 in an in vitro assay with cellular components measured by membrane filtration, radioligand displacement assay",F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35574,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25117369,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,=,1,1,=,,AC50,nM,,350001.6,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,350.0016
35575,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25118918,[],CHEMBL5291826,Binding affinity towards human HTR6 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3371,Homo sapiens,Serotonin 6 (5-HT6) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35576,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25119065,[],CHEMBL5291827,Binding affinity towards human HTR7 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3155,Homo sapiens,Serotonin 7 (5-HT7) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35577,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25119336,[],CHEMBL5291755,Compound was evaluated for inhibition of rat Cacna1c in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3762,Rattus norvegicus,Voltage-gated L-type calcium channel alpha-1C subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
35578,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120314,[],CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,,AC50,uM,UO_0000065,,10.0
35579,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25121454,[],CHEMBL5291740,Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35580,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25122619,[],CHEMBL5291742,Binding affinity towards human ADRB2 in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35581,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25123621,[],CHEMBL5291890,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
35582,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25124809,[],CHEMBL5291882,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
35583,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25125775,[],CHEMBL5291770,Binding affinity towards human CHRNA4 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1882,Homo sapiens,Neuronal acetylcholine receptor protein alpha-4 subunit,9606.0,,,AC50,uM,UO_0000065,,10.0
35584,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25127319,[],CHEMBL5291783,Binding affinity towards human DRD4 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35585,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128690,[],CHEMBL5291884,Binding affinity towards human TACR1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL249,Homo sapiens,Neurokinin 1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35586,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25129130,[],CHEMBL5291853,"Binding affinity towards human OPRK1 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35587,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25130276,[],CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
35588,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25131486,[],CHEMBL5291823,Binding affinity towards human HTR2C in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35589,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25132687,[],CHEMBL5291724,Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35590,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25133879,[],CHEMBL5291727,Binding affinity towards human ADORA3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35591,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25135117,[],CHEMBL5291763,Compound was evaluated for inhibition of human CHRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,10.0
35592,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25137399,[],CHEMBL5291769,Binding affinity towards human CHRM5 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,AC50,uM,UO_0000065,,10.0
35593,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25137512,[],CHEMBL5291795,Binding affinity towards human GABBR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2064,Homo sapiens,GABA-B receptor 1,9606.0,,,AC50,uM,UO_0000065,,10.0
35594,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25137734,[],CHEMBL5291732,Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35595,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25138360,[],CHEMBL5291911,Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35596,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25138708,[],CHEMBL5291792,Binding affinity towards human ESR1 in an in vitro cell free assay (CRO assay) measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
35597,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25139539,[],CHEMBL5291754,Compound was evaluated for inhibition of rat Cacna1b in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL5107,Rattus norvegicus,Voltage-gated N-type calcium channel alpha-1B subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
35598,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25140001,[],CHEMBL5291781,"Binding affinity towards human DRD2 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35599,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25141229,[],CHEMBL5291880,Binding affinity towards human SLC29A1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1997,Homo sapiens,Equilibrative nucleoside transporter 1,9606.0,,,AC50,uM,UO_0000065,,30.0
35600,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25142398,[],CHEMBL5291723,Compound was evaluated for inhibition of human ACHE in an vitro cell free assay measured by absorbance method,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,AC50,uM,UO_0000065,,30.0
35601,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25143379,[],CHEMBL5291737,Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35602,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25144673,[],CHEMBL5291891,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
35603,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25145850,[],CHEMBL5291881,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
35604,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25147544,[],CHEMBL5291738,Compound was evaluated for inhibition of human ADRA2C in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35605,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25148801,[],CHEMBL5291824,"Compound was evaluated for inhibition of human HTR3A in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1899,Homo sapiens,Serotonin 3a (5-HT3a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35606,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25150013,[],CHEMBL5291892,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
35607,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25151177,[],CHEMBL5291883,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
35608,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25152152,[],CHEMBL5291726,Binding affinity towards human ADORA2A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35609,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25153220,[],CHEMBL5291743,Binding affinity towards human ADRB3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35610,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25153743,[],CHEMBL5291852,Binding affinity towards human OPRD1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35611,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25154935,[],CHEMBL5291889,Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35612,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25155850,[],CHEMBL5291893,Binding affinity towards human ADRA2A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35613,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25156279,[],CHEMBL5291736,Binding affinity towards human ADRA2A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35614,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25157226,[],CHEMBL5291894,Binding affinity towards human OPRM1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35615,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25158025,[],CHEMBL5291855,Binding affinity towards human OPRM1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35616,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25159351,[],CHEMBL5291895,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,10.0
35617,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25160541,[],CHEMBL5291830,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,30.0
35618,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25161367,[],CHEMBL5291804,Binding affinity towards human GIPR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4383,Homo sapiens,Gastric inhibitory polypeptide receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35619,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25161800,[],CHEMBL5291750,Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35620,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25162971,[],CHEMBL5291751,Binding affinity towards human AVPR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1790,Homo sapiens,Vasopressin V2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35621,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25164020,[],CHEMBL5291822,Binding affinity towards human HTR2B in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35622,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25164401,[],CHEMBL5291896,Binding affinity towards human HTR1A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35623,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25164874,[],CHEMBL5291815,Binding affinity towards human HTR1A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35624,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25165871,[],CHEMBL5291870,Compound was evaluated for inhibition of human PTGS2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,AC50,uM,UO_0000065,,30.0
35625,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25167036,[],CHEMBL5291791,Binding affinity towards human ESR1 in an in vitro cell free assay (NIBR assay) measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
35626,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25169045,[],CHEMBL5291810,Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35627,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25170162,[],CHEMBL5291753,Binding affinity towards human BDKRB2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35628,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25171217,[],CHEMBL5291758,Binding affinity towards human CCKBR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL298,Homo sapiens,Cholecystokinin B receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35629,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25171991,[],CHEMBL5291802,Binding affinity towards human GCGR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1985,Homo sapiens,Glucagon receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35630,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25172435,[],CHEMBL5291803,Binding affinity towards human GHSR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4616,Homo sapiens,Ghrelin receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35631,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25173496,[],CHEMBL5291818,Binding affinity towards human HTR2A in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35632,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25174070,[],CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,,AC50,uM,UO_0000065,,30.0
35633,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25175137,[],CHEMBL5291793,Binding affinity towards human ESR2 in an in vitro cell free assay measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,AC50,uM,UO_0000065,,30.0
35634,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25175555,[],CHEMBL5291850,"Binding affinity towards human NR3C1 in an in vitro cell free assay measured by filtration, radioactivity method",B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35635,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25176671,[],CHEMBL5291744,Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL227,Homo sapiens,Type-1 angiotensin II receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35636,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25177889,[],CHEMBL5291757,Binding affinity towards human CCKAR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35637,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25179006,[],CHEMBL5291785,Binding affinity towards human EDNRA in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,AC50,uM,UO_0000065,,30.0
35638,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25179754,[],CHEMBL5291786,Binding affinity towards human EDNRB in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1785,Homo sapiens,Endothelin receptor ET-B,9606.0,,,AC50,uM,UO_0000065,,30.0
35639,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25180199,[],CHEMBL5291777,Agonist activity at human DRD1 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35640,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25181436,[],CHEMBL5291773,Binding affinity towards human CNR1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35641,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25182049,[],CHEMBL5291752,Binding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4308,Homo sapiens,Bradykinin B1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35642,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25182347,[],CHEMBL5291775,Binding affinity towards human CRHR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1800,Homo sapiens,Corticotropin releasing factor receptor 1,9606.0,,,AC50,uM,UO_0000065,,30.0
35643,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25182634,[],CHEMBL5291776,Binding affinity towards human CRHR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4069,Homo sapiens,Corticotropin releasing factor receptor 2,9606.0,,,AC50,uM,UO_0000065,,30.0
35644,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25183068,[],CHEMBL5291831,Binding affinity towards human MC3R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,AC50,uM,UO_0000065,,30.0
35645,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25184220,[],CHEMBL5291832,Binding affinity towards human MC4R in an in vitro assay with cellular components measured by scintillation proximity assay in vitro assay with cellular components,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,AC50,uM,UO_0000065,,30.0
35646,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25184991,[],CHEMBL5291858,Compound was evaluated for inhibition of human PDE4D in an in vitro cell free assay measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL288,Homo sapiens,Phosphodiesterase 4D,9606.0,,,AC50,uM,UO_0000065,,30.0
35647,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25186227,[],CHEMBL5291834,Binding affinity towards human NPY1R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,AC50,uM,UO_0000065,,30.0
35648,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187266,[],CHEMBL5291748,Binding affinity towards rat Ar in an in vitro cell free assay measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,AC50,uM,UO_0000065,,30.0
35649,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25188868,[],CHEMBL5291833,Binding affinity towards human MLNR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2203,Homo sapiens,Motilin receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35650,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25189909,[],CHEMBL5291851,Binding affinity towards human NTSR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4123,Homo sapiens,Neurotensin receptor 1,9606.0,,,AC50,uM,UO_0000065,,30.0
35651,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25190356,[],CHEMBL5291898,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
35652,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25191567,[],CHEMBL5291856,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
35653,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25192395,[],CHEMBL5291835,Binding affinity towards human NPY2R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,AC50,uM,UO_0000065,,30.0
35654,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25192702,[],CHEMBL5291862,Binding affinity towards human PGR in an in vitro cell free assay measured by fluorescence polarization method in vitro cell free assay,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35655,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25193203,[],CHEMBL5291899,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35656,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25194376,[],CHEMBL5291782,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35657,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25195183,[],CHEMBL5291900,Binding affinity towards human CHRM2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
35658,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25195586,[],CHEMBL5291766,Binding affinity towards human CHRM2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,30.0
35659,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25196556,[],CHEMBL5291794,Compound was evaluated for inhibition of human F2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL204,Homo sapiens,Thrombin,9606.0,,,AC50,uM,UO_0000065,,30.0
35660,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25197711,[],CHEMBL5291888,Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35661,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25199382,[],CHEMBL5291812,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35662,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25200322,[],CHEMBL5291921,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35663,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25201315,[],CHEMBL5291820,Agonist activity at human HTR2B in an in vitro cell-based assay (CRO assay) measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35664,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25202416,[],CHEMBL5291725,Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35665,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25203208,[],CHEMBL5291749,Binding affinity towards human AR in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1871,Homo sapiens,Androgen Receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35666,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25204141,[],CHEMBL5291863,Binding affinity towards human PGR in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35667,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25205074,[],CHEMBL5291869,Compound was evaluated for inhibition of human PTGS1 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,AC50,uM,UO_0000065,,30.0
35668,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25206007,[],CHEMBL5291871,Compound was evaluated for inhibition of human PTGS1 in an in vitro cell free assay measured by fluorescence method,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,AC50,uM,UO_0000065,,30.0
35669,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25206937,[],CHEMBL5291857,Compound was evaluated for inhibition of human PDE4A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL254,Homo sapiens,Phosphodiesterase 4A,9606.0,,,AC50,uM,UO_0000065,,30.0
35670,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25207804,[],CHEMBL5291800,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,30.0
35671,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25208396,[],CHEMBL5291730,Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35672,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25209244,[],CHEMBL5291759,Agonist activity at human CHRM1 in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
35673,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25210084,[],CHEMBL5291761,Antagonist activity human CHRM1 in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
35674,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25210944,[],CHEMBL5291887,Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35675,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25212177,[],CHEMBL5291809,Binding affinity towards human HRH1 in an in vitro assay measured by filtration,B,,,BAO_0000186,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35676,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25213425,[],CHEMBL5291765,Antagonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
35677,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25214619,[],CHEMBL5291764,Agonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
35678,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25215785,[],CHEMBL5291814,Antagonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35679,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25216704,[],CHEMBL5291813,Agonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35680,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25217840,[],CHEMBL5291901,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35681,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25218724,[],CHEMBL5291731,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35682,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25219583,[],CHEMBL5291735,Antagonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35683,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25220769,[],CHEMBL5291734,Agonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35684,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25227216,[],CHEMBL5291821,Antagonist activity at human HTR2B in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35685,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25228394,[],CHEMBL5291819,Agonist activity at human HTR2B in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
35686,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25229557,[],CHEMBL5291729,Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35687,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25231396,[],CHEMBL5291771,Agonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35688,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25233419,[],CHEMBL5291741,Agonist activity at human ADRB2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,3940106,>,1,1,>,,AC50,nM,,30000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
35689,,Not Active,6273096,[],CHEMBL1805460,Antibiotic activity against cytolysin-positive Enterococcus faecalis MMH594 infected in intestine of Caenorhabditis elegans glp-4(bn2ts);sek-1(km4) mutant infection model assessed as nematode survival at 50 to 100 ug/mL after 168 hrs by liquid infection assay,F,,,BAO_0000375,BAO_0000218,organism-based format,C/C=C(\C)C(=O)C1=C2C3=COC(/C=C/[C@@H](C)CC)=CC3=C(Cl)C(=O)[C@@]2(C)OC1=O,,,CHEMBL1799936,J Nat Prod,2011.0,,CHEMBL1802154,CHAETOVIRIDIN E,CHEMBL1802154,,0,,1441539,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
35690,,,12176057,[],CHEMBL2209268,Antimycobacterial activity against Mycobacterium tuberculosis H37Ra,F,,,BAO_0002146,BAO_0000218,organism-based format,C/C=C(\C)C(=O)C1=C2C3=COC(/C=C/[C@@H](C)CC)=CC3=C(Cl)C(=O)[C@@]2(C)OC1=O,,,CHEMBL2203104,Eur J Med Chem,2012.0,,CHEMBL1802154,CHAETOVIRIDIN E,CHEMBL1802154,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1757184,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,50.0
35691,,,13307722,[],CHEMBL2382892,Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C/C=C(\C)C(=O)C1=C2C3=COC(/C=C/[C@@H](C)CC)=CC3=C(Cl)C(=O)[C@@]2(C)OC1=O,,,CHEMBL2380220,Bioorg Med Chem Lett,2013.0,,CHEMBL1802154,CHAETOVIRIDIN E,CHEMBL1802154,4.39,0,http://www.openphacts.org/units/Nanomolar,1894666,=,1,1,=,,IC50,nM,,40600.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,uM,UO_0000065,,40.6
35692,,,20637379,[],CHEMBL4612074,Cytotoxicity against human MGC803 cells assessed as reduction in cell viability measured after 72 hrs by CCK8 assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C/C=C(\C)C(=O)C1=C2C3=COC(/C=C/[C@@H](C)CC)=CC3=C(Cl)C(=O)[C@@]2(C)OC1=O,,,CHEMBL4610092,J Nat Prod,2020.0,,CHEMBL1802154,CHAETOVIRIDIN E,CHEMBL1802154,,0,http://www.openphacts.org/units/Nanomolar,3473212,>,1,1,>,,IC50,nM,,10000.0,CHEMBL3706566,Homo sapiens,MGC-803,9606.0,,,IC50,uM,UO_0000065,,10.0
35693,,,20637390,[],CHEMBL4612075,Cytotoxicity against human AGS cells assessed as reduction in cell viability measured after 72 hrs by CCK8 assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C/C=C(\C)C(=O)C1=C2C3=COC(/C=C/[C@@H](C)CC)=CC3=C(Cl)C(=O)[C@@]2(C)OC1=O,,,CHEMBL4610092,J Nat Prod,2020.0,,CHEMBL1802154,CHAETOVIRIDIN E,CHEMBL1802154,,0,http://www.openphacts.org/units/Nanomolar,3473212,>,1,1,>,,IC50,nM,,10000.0,CHEMBL613860,Homo sapiens,AGS,9606.0,,,IC50,uM,UO_0000065,,10.0
35694,,Inconclusive,3706487,[],CHEMBL1613914,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,4.6,0,http://www.openphacts.org/units/Nanomolar,1157689,=,7,1,=,,Potency,nM,,25118.9,CHEMBL1293226,Homo sapiens,Lysine-specific demethylase 4D-like,9606.0,,,Potency,um,UO_0000065,,25.1189
35695,,Active,3743273,[],CHEMBL1613914,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,5.15,0,http://www.openphacts.org/units/Nanomolar,980078,=,7,1,=,,Potency,nM,,7079.5,CHEMBL1293226,Homo sapiens,Lysine-specific demethylase 4D-like,9606.0,,,Potency,um,UO_0000065,,7.0795
35696,,Inconclusive,3931015,[],CHEMBL1614364,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000357,single protein format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,"{'bei': '28.41', 'le': '0.54', 'lle': '3.68', 'sei': '5.21'}",CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,4.35,0,http://www.openphacts.org/units/Nanomolar,980078,=,7,1,=,,Potency,nM,,44668.4,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,um,UO_0000065,,44.6684
35697,,Active,5044137,[],CHEMBL1614080,PUBCHEM_BIOASSAY: Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics. (Class of assay: confirmatory) ,F,,,BAO_0002144,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,,0,http://www.openphacts.org/units/Nanomolar,980078,=,7,1,=,,IC90,nM,,1877.0,CHEMBL612545,,Unchecked,,,,IC90,um,UO_0000065,,1.877
35698,,Inconclusive,5063669,[],CHEMBL1614079,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,5.0,0,http://www.openphacts.org/units/Nanomolar,980078,=,7,1,=,,Potency,nM,,10000.0,CHEMBL2392,Homo sapiens,DNA polymerase beta,9606.0,,,Potency,um,UO_0000065,,10.0
35699,,inactive,6960288,[],CHEMBL1794553,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860]",F,,,BAO_0000186,BAO_0000219,cell-based format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,,0,http://www.openphacts.org/units/Nanomolar,980078,,7,1,,,Potency,nM,,28183.8,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Potency,uM,UO_0000065,,28.1838
35700,,inconclusive,14250649,[],CHEMBL1614166,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000357,single protein format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,,0,http://www.openphacts.org/units/Nanomolar,980078,,7,1,,,Potency,nM,,158.5,CHEMBL1293317,Homo sapiens,Muscleblind-like protein 1,9606.0,,,Potency,uM,UO_0000065,,0.1585
35701,,inconclusive,14377581,[],CHEMBL1614211,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,,0,http://www.openphacts.org/units/Nanomolar,980078,,7,1,,,Potency,nM,,35481.3,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606.0,,,Potency,uM,UO_0000065,,35.4813
35702,,inactive,15471655,[],CHEMBL3561973,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,,0,http://www.openphacts.org/units/Nanomolar,2474061,,7,1,,,AC50,nM,,290.0,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,0.29
35703,,inactive,15480731,[],CHEMBL3562135,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,,0,http://www.openphacts.org/units/Nanomolar,2474061,,7,1,,,AC50,nM,,281.8,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,0.2818
35704,,inactive,15483166,[],CHEMBL3562085,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,,0,http://www.openphacts.org/units/Micromolar,2474061,,7,0,,,Ac50,uM,,0.2818,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,0.2818382931
35705,,inactive,15505955,[],CHEMBL3562133,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,,0,http://www.openphacts.org/units/Nanomolar,2474061,,7,1,,,AC50,nM,,12589.3,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,12.5893
35706,,inactive,15509266,[],CHEMBL3562112,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,,0,http://www.openphacts.org/units/Micromolar,2474061,,7,0,,,Ac50,uM,,0.2818,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,0.2818382931
35707,,inactive,15523242,[],CHEMBL3562088,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,Nc1ccc(C(=O)[O-])c(O)c1.[Na+],,,CHEMBL1201862,,,,CHEMBL1200966,SODIUM AMINOSALICYLATE,CHEMBL1169,,0,http://www.openphacts.org/units/Micromolar,2474061,,7,0,,,Ac50,uM,,12.59,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,12.5892541179
35708,,,6273089,[],CHEMBL1803148,Antimicrobial activity against Magnaporthe grisea mycelia assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(O)(C(C)C(C)O)[C@@H](C(=O)O)[C@H]3C2=CO1,,,CHEMBL1799936,J Nat Prod,2011.0,,CHEMBL1802151,CHAETOVIRIDIN B,CHEMBL1802151,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441536,=,1,1,=,,MIC,ug.mL-1,,1.23,CHEMBL612468,Pyricularia grisea,Pyricularia grisea,148305.0,,,MIC,ug ml-1,UO_0000274,,1.23
35709,,,6273091,[],CHEMBL1803147,Antimicrobial activity against Pythium ultimum mycelia assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(O)(C(C)C(C)O)[C@@H](C(=O)O)[C@H]3C2=CO1,,,CHEMBL1799936,J Nat Prod,2011.0,,CHEMBL1802151,CHAETOVIRIDIN B,CHEMBL1802151,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441536,=,1,1,=,,MIC,ug.mL-1,,33.3,CHEMBL612323,Globisporangium ultimum,Globisporangium ultimum,2052682.0,,,MIC,ug ml-1,UO_0000274,,33.3
35710,,Not Active,6273093,[],CHEMBL1805460,Antibiotic activity against cytolysin-positive Enterococcus faecalis MMH594 infected in intestine of Caenorhabditis elegans glp-4(bn2ts);sek-1(km4) mutant infection model assessed as nematode survival at 50 to 100 ug/mL after 168 hrs by liquid infection assay,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(O)(C(C)C(C)O)[C@@H](C(=O)O)[C@H]3C2=CO1,,,CHEMBL1799936,J Nat Prod,2011.0,,CHEMBL1802151,CHAETOVIRIDIN B,CHEMBL1802151,,0,,1441536,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
35711,,,6273088,[],CHEMBL1803148,Antimicrobial activity against Magnaporthe grisea mycelia assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(=O)C(C(=O)[C@@H](C)[C@@H](C)O)=C3C2=CO1,,,CHEMBL1799936,J Nat Prod,2011.0,,CHEMBL1802150,CHAETOVIRIDIN A,CHEMBL1802150,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441535,=,1,1,=,,MIC,ug.mL-1,,1.23,CHEMBL612468,Pyricularia grisea,Pyricularia grisea,148305.0,,,MIC,ug ml-1,UO_0000274,,1.23
35712,,,6273090,[],CHEMBL1803147,Antimicrobial activity against Pythium ultimum mycelia assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(=O)C(C(=O)[C@@H](C)[C@@H](C)O)=C3C2=CO1,,,CHEMBL1799936,J Nat Prod,2011.0,,CHEMBL1802150,CHAETOVIRIDIN A,CHEMBL1802150,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441535,=,1,1,=,,MIC,ug.mL-1,,33.3,CHEMBL612323,Globisporangium ultimum,Globisporangium ultimum,2052682.0,,,MIC,ug ml-1,UO_0000274,,33.3
35713,,Not Active,6273092,[],CHEMBL1805460,Antibiotic activity against cytolysin-positive Enterococcus faecalis MMH594 infected in intestine of Caenorhabditis elegans glp-4(bn2ts);sek-1(km4) mutant infection model assessed as nematode survival at 50 to 100 ug/mL after 168 hrs by liquid infection assay,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(=O)C(C(=O)[C@@H](C)[C@@H](C)O)=C3C2=CO1,,,CHEMBL1799936,J Nat Prod,2011.0,,CHEMBL1802150,CHAETOVIRIDIN A,CHEMBL1802150,,0,,1441535,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
35714,,,20637378,[],CHEMBL4612074,Cytotoxicity against human MGC803 cells assessed as reduction in cell viability measured after 72 hrs by CCK8 assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(=O)C(C(=O)[C@@H](C)[C@@H](C)O)=C3C2=CO1,,,CHEMBL4610092,J Nat Prod,2020.0,,CHEMBL1802150,CHAETOVIRIDIN A,CHEMBL1802150,,0,http://www.openphacts.org/units/Nanomolar,3473211,>,1,1,>,,IC50,nM,,10000.0,CHEMBL3706566,Homo sapiens,MGC-803,9606.0,,,IC50,uM,UO_0000065,,10.0
35715,,,20637389,[],CHEMBL4612075,Cytotoxicity against human AGS cells assessed as reduction in cell viability measured after 72 hrs by CCK8 assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(=O)C(C(=O)[C@@H](C)[C@@H](C)O)=C3C2=CO1,,,CHEMBL4610092,J Nat Prod,2020.0,,CHEMBL1802150,CHAETOVIRIDIN A,CHEMBL1802150,,0,http://www.openphacts.org/units/Nanomolar,3473211,>,1,1,>,,IC50,nM,,10000.0,CHEMBL613860,Homo sapiens,AGS,9606.0,,,IC50,uM,UO_0000065,,10.0
35716,,Not Active,6273095,[],CHEMBL1805460,Antibiotic activity against cytolysin-positive Enterococcus faecalis MMH594 infected in intestine of Caenorhabditis elegans glp-4(bn2ts);sek-1(km4) mutant infection model assessed as nematode survival at 50 to 100 ug/mL after 168 hrs by liquid infection assay,F,,,BAO_0000375,BAO_0000218,organism-based format,CC(O)C(C)C1(O)O[C@]2(C)C(=O)C(Cl)=C3C=C(/C=C/[C@@H](C)[C@@H](C)O)OC=C3[C@@H]2[C@@H]1C(=O)O,,,CHEMBL1799936,J Nat Prod,2011.0,,CHEMBL1802153,CHAETOVIRIDIN D,CHEMBL1802153,,0,,1441538,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
35717,,Not Active,6273094,[],CHEMBL1805460,Antibiotic activity against cytolysin-positive Enterococcus faecalis MMH594 infected in intestine of Caenorhabditis elegans glp-4(bn2ts);sek-1(km4) mutant infection model assessed as nematode survival at 50 to 100 ug/mL after 168 hrs by liquid infection assay,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(=O)[C@@H](C(=O)[C@@H](C)[C@H](C)O)[C@H]3C2=CO1,,,CHEMBL1799936,J Nat Prod,2011.0,,CHEMBL1802152,CHAETOVIRIDIN C,CHEMBL1802152,,0,,1441537,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
35718,,Not Active,6273103,[],CHEMBL1805460,Antibiotic activity against cytolysin-positive Enterococcus faecalis MMH594 infected in intestine of Caenorhabditis elegans glp-4(bn2ts);sek-1(km4) mutant infection model assessed as nematode survival at 50 to 100 ug/mL after 168 hrs by liquid infection assay,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H](C)/C=C/C1=CC2=C(Cl)C(=O)[C@@]3(C)OC(=O)C4=C(C(C)C(C)O)OC(O1)C2(O)C43O,,,CHEMBL1799936,J Nat Prod,2011.0,,CHEMBL1802160,CHAETOVIRIDIN I,CHEMBL1802160,,0,,1441546,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
35719,,,57424,[],CHEMBL749419,"Minimum inhibitory concentration against Mycobacterium tuberculosis var. bovis strain at 310K, with value expressed as pMIC i.e. -log of MIC (ug/mL).",F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148365,J Med Chem,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,235523,=,1,0,=,,pMIC,,,4.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,pMIC,,,,4.2
35720,,Resistant,130842,[],CHEMBL747047,The compound was tested for its ability to inhibit the growth of Mycobacterium avium; Resistant,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1132871,Bioorg Med Chem Lett,2000.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,5067,,1,0,,,MIC,ug.mL-1,,,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,
35721,,Sensitive,130843,[],CHEMBL749711,The compound was tested for its ability to inhibit the growth of Mycobacterium tuberculosis strain H37Rv; Sensitive,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1132871,Bioorg Med Chem Lett,2000.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,5067,,1,0,,,MIC,ug.mL-1,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,
35722,,Resistant,130844,[],CHEMBL747188,The compound was tested for its ability to inhibit the growth of Mycobacterium tuberculosis strain H6/99; Resistant,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1132871,Bioorg Med Chem Lett,2000.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,5067,,1,0,,,MIC,ug.mL-1,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,
35723,,,136493,[],CHEMBL750597,Compound was tested for inhibitory activity against Mycobacterium tuberculosis H37Rv ATCC 27294 and the activity is expressed as minimum inhibitory concentration (MIC).,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1131006,J Med Chem,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144634,<,1,1,<,,MIC,ug.mL-1,,0.02,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.02
35724,,,137919,[],CHEMBL817662,In vitro cytotoxicity against vero cells,F,,,BAO_0000179,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1132675,Bioorg Med Chem Lett,1999.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,188818,=,1,0,=,,MTD50,ug ml-1,,32.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,MTD50,ug ml-1,UO_0000274,,32.0
35725,,,137920,[],CHEMBL751179,In vitro antibacterial activity against Mycobacterium tuberculosis 103471,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1132675,Bioorg Med Chem Lett,1999.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,188818,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35726,,,137921,[],CHEMBL752337,In vitro antibacterial activity against Mycobacterium smegmatis 103599,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1132675,Bioorg Med Chem Lett,1999.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,188818,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,64.0
35727,,,137922,[],CHEMBL858162,In vitro antibacterial activity against Mycobacterium marinum 6423,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1132675,Bioorg Med Chem Lett,1999.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,188818,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,,MIC,ug ml-1,UO_0000274,,16.0
35728,,,137923,[],CHEMBL748691,In vitro antibacterial activity against Mycobacterium gordonae 6427,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1132675,Bioorg Med Chem Lett,1999.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,188818,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614986,Mycobacterium gordonae,Mycobacterium gordonae,1778.0,,,MIC,ug ml-1,UO_0000274,,32.0
35729,,,137924,[],CHEMBL745122,In vitro antibacterial activity against Mycobacterium avium 103317,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1132675,Bioorg Med Chem Lett,1999.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,188818,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,32.0
35730,,,151851,[],CHEMBL712158,Cytotoxicity of compound against mock-infected MT-4 cells was evaluated by MTT assay,F,,,BAO_0000187,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,>,1,1,>,,CC50,nM,,100000.0,CHEMBL388,Homo sapiens,MT4,9606.0,,,CC50,uM,UO_0000065,,100.0
35731,,,151852,[],CHEMBL746404,In vitro anti-mycobacterial activity against Mycobacterium tuberculosis ATCC 27294 was determined,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC50,nM,,90.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,uM,UO_0000065,,0.09
35732,,,151853,[],CHEMBL749515,"In vitro anti-mycobacterial activity against Mycobacterium tuberculosis ATCC 27294, determined by the MTT method",F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC90,nM,,9800.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,9.8
35733,,,151854,[],CHEMBL746405,In vitro anti-mycobacterial activity against Mycobacterium tuberculosis C.I. 1104 was determined,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC50,nM,,60.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,uM,UO_0000065,,0.06
35734,,,151855,[],CHEMBL749516,"In vitro anti-mycobacterial activity against Mycobacterium tuberculosis C.I. 1104, determined by the MTT method",F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC90,nM,,200.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.2
35735,,,151856,[],CHEMBL745307,In vitro anti-mycobacterial activity against Mycobacterium avium complex was determined,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC50,nM,,1400.0,CHEMBL614981,Mycobacterium,Mycobacterium,1763.0,,,MIC50,uM,UO_0000065,,1.4
35736,,,151857,[],CHEMBL745308,In vitro anti-mycobacterial activity against Mycobacterium smegmatis determined by the MTT method,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC90,nM,,4700.0,CHEMBL614981,Mycobacterium,Mycobacterium,1763.0,,,MIC90,uM,UO_0000065,,4.7
35737,,,151858,[],CHEMBL748703,In vitro anti-mycobacterial activity against Mycobacterium smegmatis was determined,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC50,nM,,1800.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC50,uM,UO_0000065,,1.8
35738,,,151859,[],CHEMBL748705,In vitro anti-mycobacterial activity against Mycobacterium smegmatis determined by the MTT method,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC90,nM,,6700.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC90,uM,UO_0000065,,6.7
35739,,,151860,[],CHEMBL748684,In vitro anti-mycobacterial activity against Mycobacterium fortuitum was determined,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,>,1,1,>,,MIC50,nM,,100000.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC50,uM,UO_0000065,,100.0
35740,,,151861,[],CHEMBL749509,In vitro anti-mycobacterial activity against streptomycin resistant Mycobacterium tuberculosis ATCC 35820 was determined,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC50,nM,,1300.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,uM,UO_0000065,,1.3
35741,,,151862,[],CHEMBL749679,In vitro anti-mycobacterial activity against streptomycin resistant Mycobacterium tuberculosis ATCC 35820 determined by the MTT method,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,>,1,1,>,,MIC90,nM,,100000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,100.0
35742,,,151863,[],CHEMBL746408,In vitro anti-mycobacterial activity against pirazynamide resistant Mycobacterium tuberculosis ATCC 35828 was determined,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC50,nM,,100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,uM,UO_0000065,,0.1
35743,,,151864,[],CHEMBL749520,In vitro anti-mycobacterial activity against pirazynamide resistant Mycobacterium tuberculosis ATCC 35828 determined by the MTT method,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,>,1,1,>,,MIC90,nM,,100000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,100.0
35744,,,151865,[],CHEMBL879282,In vitro anti-mycobacterial activity against ethambutol resistant Mycobacterium tuberculosis ATCC 35837 was determined,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC50,nM,,200.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,uM,UO_0000065,,0.2
35745,,,151866,[],CHEMBL749518,In vitro anti-mycobacterial activity against ethambutol resistant Mycobacterium tuberculosis ATCC 35837 determined by the MTT method,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149222,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,61504,=,1,1,=,,MIC90,nM,,13000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,13.0
35746,,,175164,[],CHEMBL751176,Compound was tested in vitro for growth inhibition activity against Mycobacterium tuberculosis H37Rv in Bactec 6A media.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130782,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,332546,<,1,1,<,,MIC,nM,,20.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.02
35747,,,175165,[],CHEMBL744028,Compound was tested in vitro for growth inhibition activity against Mycobacterium tuberculosis H37Rv in Bactec 12B media.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130782,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,332546,<,1,1,<,,MIC,nM,,160.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.16
35748,,,211848,[],CHEMBL751400,In vitro minimum inhibitory concentration against Mycobacterium tuberculosis CIP 103471 was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130838,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,56648,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35749,,,211849,[],CHEMBL815809,Minimal toxic dose that induced a reduction of 50% of cell growth in Vero cell line infected with Mycobacterium tuberculosis CIP 103471,F,,,BAO_0000179,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1130838,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,56648,=,1,0,=,,MTD50,ug ml-1,,32.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,MTD50,ug ml-1,UO_0000274,,32.0
35750,,,211850,[],CHEMBL745127,In vitro cytotoxicity against Mycobacterium avium (CIP 103317) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130838,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,56648,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,32.0
35751,,,211851,[],CHEMBL751175,In vitro cytotoxicity against Mycobacterium smegmatis CIP (103599) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130838,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,56648,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,64.0
35752,,,211852,[],CHEMBL747262,In vitro cytotoxicity against Mycobacterium gordonae (CIP 6427) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130838,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,56648,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614986,Mycobacterium gordonae,Mycobacterium gordonae,1778.0,,,MIC,ug ml-1,UO_0000274,,32.0
35753,,,211853,[],CHEMBL751644,In vitro cytotoxicity against Mycobacterium marinum (CIP 6423) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130838,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,56648,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,,MIC,ug ml-1,UO_0000274,,16.0
35754,,,223234,[],CHEMBL858377,Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv (ATCC 27294) in BACTEC 6A medium,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134471,J Med Chem,2001.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,63545,=,1,1,=,,MIC,nM,,150.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.15
35755,,,223235,[],CHEMBL858377,Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv (ATCC 27294) in BACTEC 6A medium,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134471,J Med Chem,2001.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63545,=,1,1,=,,MIC,ug.mL-1,,0.018,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.018
35756,,,307397,[],CHEMBL751557,Antitubercular activity against Mycobacterium tuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1136674,Bioorg Med Chem Lett,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,29982,=,1,1,=,,MIC,ug.mL-1,,0.09,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.09
35757,,Not Determined,338176,[],CHEMBL813226,In vitro inhibition of translocase I; Not determined.,B,,,BAO_0000190,BAO_0000357,single protein format,NNC(=O)c1ccncc1,,,CHEMBL1136175,Bioorg Med Chem Lett,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,177954,,1,0,,,IC50,ug.mL-1,,,CHEMBL3957,Escherichia coli K-12,Phospho-N-acetylmuramoyl-pentapeptide-transferase,83333.0,,,IC50,ng ml-1,UO_0000274,,
35758,,Not Determined,338177,[],CHEMBL752180,Antimycobacterial activity was determined against Mycobacterium smegmatis SANK75075,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1136175,Bioorg Med Chem Lett,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,177954,,1,0,,,MIC,ug.mL-1,,,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,
35759,,,338178,[],CHEMBL858007,Antimycobacterial activity against Mycobacterium avium NIHJ1605,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1136175,Bioorg Med Chem Lett,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,177954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,1.0
35760,,,338179,[],CHEMBL747268,Antimycobacterial activity against Mycobacterium intracellular ATCC 1954 E-3,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1136175,Bioorg Med Chem Lett,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,177954,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,8.0
35761,,,338180,[],CHEMBL751969,Antimycobacterial activity against Mycobacterium kansasii ATCC 12478,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1136175,Bioorg Med Chem Lett,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,177954,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,ug ml-1,UO_0000274,,2.0
35762,,,400508,[],CHEMBL748932,"In vitro inhibition of Mycobacterium tuberculosis H37Rv, determined at 20 ug/mL",F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149191,J Med Chem,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,219997,=,1,1,=,,Inhibition,%,,68.7,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Inhibition,%,UO_0000187,,68.7
35763,,,400509,[],CHEMBL748931,"In vitro inhibition of Mycobacterium tuberculosis H37Rv, determined at 2 ug/mL",F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149191,J Med Chem,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,219997,=,1,1,=,,Inhibition,%,,59.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Inhibition,%,UO_0000187,,59.1
35764,,,400510,[],CHEMBL748930,"In vitro inhibition of Mycobacterium tuberculosis H37Rv, determined at 0.2 ug/mL",F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149191,J Med Chem,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,219997,=,1,1,=,,Inhibition,%,,49.7,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Inhibition,%,UO_0000187,,49.7
35765,,,400511,[],CHEMBL749511,Minimal inhibitory activity of compound against Mycobacterium tuberculosis H37Rv,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149191,J Med Chem,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,219997,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,0.25
35766,,,474108,[],CHEMBL751561,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium tuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1129577,J Med Chem,1996.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314387,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
35767,,,531285,[],CHEMBL752459,In vitro anti-mycobacterial activity against Mycobacterium tuberculosis strain H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1135585,J Med Chem,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,212985,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.05
35768,,,531286,[],CHEMBL752459,In vitro anti-mycobacterial activity against Mycobacterium tuberculosis strain H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1135585,J Med Chem,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,212985,=,1,1,=,,MIC,nM,,360.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.36
35769,,,531287,[],CHEMBL818401,In vitro cytotoxicity against VERO cell line,F,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1135585,J Med Chem,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,212985,>,1,1,>,,IC50,ug.mL-1,,1000.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,ug ml-1,UO_0000274,,1000.0
35770,,,531288,[],CHEMBL818401,In vitro cytotoxicity against VERO cell line,F,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1135585,J Med Chem,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,212985,>,1,1,>,,IC50,nM,,7000000.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,uM,UO_0000065,,7000.0
35771,,,531718,[],CHEMBL727410,Antitubercular activity (3.1 mg/kg) in the 31-day murine mice model,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1121743,J Med Chem,1981.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,36409,=,1,0,=,,Survival,%,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Survival,%,UO_0000187,,100.0
35772,,,531719,[],CHEMBL727415,Antitubercular activity (6.25 mg/kg) in the 31-day murine mice model,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1121743,J Med Chem,1981.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,36409,=,1,0,=,,Survival,%,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Survival,%,UO_0000187,,100.0
35773,,,531720,[],CHEMBL726666,Antitubercular activity (12.5 mg/kg) in the 31-day murine mice model,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1121743,J Med Chem,1981.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,36409,=,1,0,=,,Survival,%,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Survival,%,UO_0000187,,100.0
35774,,,546439,[],CHEMBL744957,Antimycobacterial activity against Mycobacterium avium (NIHJ1605),F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1136174,Bioorg Med Chem Lett,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,177418,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,1.0
35775,,,546440,[],CHEMBL747267,Antimycobacterial activity against Mycobacterium intracellular (ATCC 1954 E-3),F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1136174,Bioorg Med Chem Lett,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,177418,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,8.0
35776,,,546441,[],CHEMBL751968,Antimycobacterial activity against Mycobacterium kansasii (ATCC12478),F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1136174,Bioorg Med Chem Lett,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,177418,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,ug ml-1,UO_0000274,,2.0
35777,,Not Determined,658005,[],CHEMBL681307,Displacement of [3H]- muscimol from GABA-A receptor from rat cerebellum membrane (ND = no data),B,,,BAO_0000201,BAO_0000221,tissue-based format,NNC(=O)c1ccncc1,,,CHEMBL1122999,J Med Chem,1985.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,311500,,1,0,,,Inhibition,%,,,CHEMBL1907607,Rattus norvegicus,GABA-A receptor; anion channel,10116.0,,,Inhibition,%,UO_0000187,,
35778,,Not Determined,658006,[],CHEMBL650182,Percent inhibition of [3H]- Diazepam binding to GABA-A Benzodiazepine receptor of rat frontal cortex membranes (ND = no data),B,,,BAO_0000201,BAO_0000249,cell membrane format,NNC(=O)c1ccncc1,,,CHEMBL1122999,J Med Chem,1985.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,311500,,1,0,,,Inhibition,%,,,CHEMBL1907607,Rattus norvegicus,GABA-A receptor; anion channel,10116.0,,,Inhibition,%,UO_0000187,,
35779,,,658007,[],CHEMBL683659,Percent of enzyme inhibition by Glutamate decarboxylase assay method,B,,,BAO_0000201,BAO_0000357,single protein format,NNC(=O)c1ccncc1,,,CHEMBL1122999,J Med Chem,1985.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,311500,=,1,1,=,,Inhibition,%,,42.0,CHEMBL3758,Rattus norvegicus,Glutamate decarboxylase 67 kDa isoform,10116.0,,,Inhibition,%,UO_0000187,,42.0
35780,,Not Determined,658008,[],CHEMBL677638,Percent of enzyme inhibition by Gamma-amino-N-butyrate transaminase assay method; ND means no data,B,,,BAO_0000201,BAO_0000357,single protein format,NNC(=O)c1ccncc1,,,CHEMBL1122999,J Med Chem,1985.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,311500,,1,0,,,Inhibition,%,,,CHEMBL3148,Rattus norvegicus,Gamma-amino-N-butyrate transaminase,10116.0,,,Inhibition,%,UO_0000187,,
35781,,,709799,[],CHEMBL715913,Activity against Mycobacterium tuberculosis (H37Rv) using the standard BACTEC radiometric growth assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1133632,J Med Chem,2000.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,211581,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.1
35782,,,772077,[],CHEMBL746402,Antibacterial activity against Mycobacterium tuberculosis H37Rv.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1122862,J Med Chem,1985.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,84287,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.05
35783,,,772078,[],CHEMBL746401,Tested for antibacterial activity against Mycobacterium tuberculosis H37Rv streptomycin resistant strain,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1122862,J Med Chem,1985.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,84287,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.05
35784,,,772079,[],CHEMBL746400,Tested for antibacterial activity against Mycobacterium tuberculosis H37Rv kanamycin resistant strain,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1122862,J Med Chem,1985.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,84287,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.05
35785,,,772080,[],CHEMBL746399,Tested for antibacterial activity against Mycobacterium tuberculosis H37Rv isonicotinic acid hydrazide-resistant strain,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1122862,J Med Chem,1985.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,84287,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,100.0
35786,,,772081,[],CHEMBL751971,Antibacterial activity against Mycobacterium kansasii,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1122862,J Med Chem,1985.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,84287,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,ug ml-1,UO_0000274,,1.56
35787,,,772082,[],CHEMBL751964,Antibacterial activity against Mycobacterium intracellular.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1122862,J Med Chem,1985.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,84287,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,6.25
35788,,,785960,[],CHEMBL751398,"In vitro antimicrobacterial activity to inhibit 90% of Mycobacterium tuberculosis H37Rv (Rifampin and Isoniazid susceptible ATCC 27294 strain), relative to that of controls",F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1133318,Bioorg Med Chem Lett,2000.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,311597,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.05
35789,,,785961,[],CHEMBL820902,Compound was tested for its cytotoxicity on Vero cells,F,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1133318,Bioorg Med Chem Lett,2000.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,311597,>,1,1,>,,IC50,ug.mL-1,,1000.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,ug ml-1,UO_0000274,,1000.0
35790,,,802743,[],CHEMBL747192,Ability to inhibit 100%growth against Mycobacterium tuberculosis H37Rv in Youman's medium,F,,,BAO_0002752,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124611,J Med Chem,1989.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,143703,=,1,0,=,,Concentration,ug ml-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Concentration,ug ml-1,UO_0000274,,1.0
35791,,,802744,[],CHEMBL747193,Ability to inhibit 100%growth against Mycobacterium tuberculosis H37Rv in Youman's medium with 10% bovine serum,F,,,BAO_0002752,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124611,J Med Chem,1989.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,143703,=,1,0,=,,Concentration,ug ml-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Concentration,ug ml-1,UO_0000274,,1.0
35792,,,802745,[],CHEMBL747197,Ability to inhibit partial growth (50+/-10%) against Mycobacterium tuberculosis H37Rv in Youman's medium,F,,,BAO_0002752,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124611,J Med Chem,1989.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,143703,=,1,0,=,,Concentration,ug ml-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Concentration,ug ml-1,UO_0000274,,0.1
35793,,,802746,[],CHEMBL747198,Ability to inhibit partial growth (50+/-10%) against Mycobacterium tuberculosis H37Rv in Youman's medium with 10% bovine serum,F,,,BAO_0002752,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124611,J Med Chem,1989.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,143703,=,1,0,=,,Concentration,ug ml-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Concentration,ug ml-1,UO_0000274,,0.5
35794,,,802747,[],CHEMBL747195,Ability to inhibit 100%growth against Mycobacterium tuberculosis strain no: 22443 in Youman's medium.,F,,,BAO_0002752,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124611,J Med Chem,1989.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,143703,=,1,0,=,,Concentration,ug ml-1,,150.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Concentration,ug ml-1,UO_0000274,,150.0
35795,,,802748,[],CHEMBL750953,Ability to inhibit partial growth (50+/-10%) against Mycobacterium tuberculosis strain no: 22443 in Youman's medium,F,,,BAO_0002752,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124611,J Med Chem,1989.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,143703,=,1,0,=,,Concentration,ug ml-1,,100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Concentration,ug ml-1,UO_0000274,,100.0
35796,,,802749,[],CHEMBL747196,Ability to inhibit 100%growth against Mycobacterium tuberculosis strain no: 312 in Youman's medium.,F,,,BAO_0002752,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124611,J Med Chem,1989.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,143703,=,1,0,=,,Concentration,ug ml-1,,100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Concentration,ug ml-1,UO_0000274,,100.0
35797,,,802750,[],CHEMBL750954,Ability to inhibit partial growth (50+/-10%) against Mycobacterium tuberculosis strain no: 312 in Youman's medium,F,,,BAO_0002752,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124611,J Med Chem,1989.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,143703,=,1,0,=,,Concentration,ug ml-1,,50.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Concentration,ug ml-1,UO_0000274,,50.0
35798,,,861573,[],CHEMBL768709,Effect on plasma amine oxidase (0.1 uM) after 0 min of incubation at pH 7.2,B,,,BAO_0000190,BAO_0000366,cell-free format,NNC(=O)c1ccncc1,,,CHEMBL1124086,J Med Chem,1988.0,,CHEMBL64,ISONIAZID,CHEMBL64,4.0,0,http://www.openphacts.org/units/Nanomolar,328308,=,1,1,=,,IC50,nM,,100000.0,CHEMBL612545,,Unchecked,,,,I50,uM,UO_0000065,,100.0
35799,,,861574,[],CHEMBL768707,Effect on plasma amine oxidase (0.1 uM) after 15 min of incubation at pH 7.2,B,,,BAO_0000190,BAO_0000366,cell-free format,NNC(=O)c1ccncc1,,,CHEMBL1124086,J Med Chem,1988.0,,CHEMBL64,ISONIAZID,CHEMBL64,5.0,0,http://www.openphacts.org/units/Nanomolar,328308,=,1,1,=,,IC50,nM,,10000.0,CHEMBL612545,,Unchecked,,,,I50,uM,UO_0000065,,10.0
35800,,,861575,[],CHEMBL768708,Effect on plasma amine oxidase (0.1 uM) after 30 min of incubation at pH 7.2,B,,,BAO_0000190,BAO_0000366,cell-free format,NNC(=O)c1ccncc1,,,CHEMBL1124086,J Med Chem,1988.0,,CHEMBL64,ISONIAZID,CHEMBL64,5.0,0,http://www.openphacts.org/units/Nanomolar,328308,=,1,1,=,,IC50,nM,,10000.0,CHEMBL612545,,Unchecked,,,,I50,uM,UO_0000065,,10.0
35801,,,861576,[],CHEMBL768710,Effect on plasma amine oxidase (0.1 uM) after 60 min of incubation at pH 7.2,B,,,BAO_0000190,BAO_0000366,cell-free format,NNC(=O)c1ccncc1,,,CHEMBL1124086,J Med Chem,1988.0,,CHEMBL64,ISONIAZID,CHEMBL64,5.3,0,http://www.openphacts.org/units/Nanomolar,328308,=,1,1,=,,IC50,nM,,5000.0,CHEMBL612545,,Unchecked,,,,I50,uM,UO_0000065,,5.0
35802,,,861577,[],CHEMBL786078,Brain mitochondrial activity measured at 0 min of incubation at 100 uM concentration,F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124086,J Med Chem,1988.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,328308,=,1,1,=,,Inhibition,%,,19.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Inhibition,%,UO_0000187,,19.0
35803,,,861578,[],CHEMBL786081,Brain mitochondrial activity measured at 120 min of incubation at 100 uM concentration,F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124086,J Med Chem,1988.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,328308,=,1,1,=,,Inhibition,%,,22.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Inhibition,%,UO_0000187,,22.0
35804,,,861579,[],CHEMBL786077,Brain mitochondrial activity measured at 0 min of incubation at 10 uM concentration,F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124086,J Med Chem,1988.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,328308,=,1,1,=,,Inhibition,%,,14.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Inhibition,%,UO_0000187,,14.0
35805,,,861580,[],CHEMBL786080,Brain mitochondrial activity measured at 120 min of incubation at 10 uM concentration,F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124086,J Med Chem,1988.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,328308,=,1,1,=,,Inhibition,%,,16.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Inhibition,%,UO_0000187,,16.0
35806,,,861581,[],CHEMBL786076,Brain mitochondrial activity measured at 0 min of incubation at 1 uM concentration,F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124086,J Med Chem,1988.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,328308,=,1,1,=,,Inhibition,%,,12.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Inhibition,%,UO_0000187,,12.0
35807,,,861582,[],CHEMBL786079,Brain mitochondrial activity measured at 120 min of incubation at 1 uM concentration,F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1124086,J Med Chem,1988.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,328308,=,1,1,=,,Inhibition,%,,16.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Inhibition,%,UO_0000187,,16.0
35808,,,889440,[],CHEMBL634283,Partition coefficient (logD6.5),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,NNC(=O)c1ccncc1,,,CHEMBL1133765,J Med Chem,2000.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,156968,=,1,1,=,,LogD,,,-0.7,CHEMBL2362975,,No relevant target,,,,logD,,,,-0.7
35809,,,889441,[],CHEMBL633649,Delta logD (logD6.5 - logD7.4),A,,,BAO_0000179,BAO_0000019,assay format,NNC(=O)c1ccncc1,,,CHEMBL1133765,J Med Chem,2000.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,156968,=,1,0,=,,delta logD,,,0.0,CHEMBL612558,,ADMET,,,,delta logD,,,,0.0
35810,,,889442,[],CHEMBL633098,Oral bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1133765,J Med Chem,2000.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,156968,>,1,1,>,,F,%,,80.0,CHEMBL612558,,ADMET,,,,F,%,UO_0000187,,80.0
35811,,Not Determined,889443,[],CHEMBL874960,Ionization constant (pKa),P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,NNC(=O)c1ccncc1,,,CHEMBL1133765,J Med Chem,2000.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,156968,,1,0,,,pKa,,,,CHEMBL2362975,,No relevant target,,,,pKa,,,,
35812,,,1048725,[],CHEMBL750793,Growth inhibitory activity against Mycobacterium tuberculosis H37R,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145788,J Med Chem,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,141708,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.05
35813,,,1054242,[],CHEMBL745795,Minimum inhibitory concentration against Mycobacterium tuberculosis using microplate alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1136392,Bioorg Med Chem Lett,2003.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,82355,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.04
35814,,,1137008,[],CHEMBL818414,In vitro cytotoxicity against VERO cells.,F,,,BAO_0000179,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1130637,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184881,=,1,0,=,,MTD50,ug ml-1,,32.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,MTD50,ug ml-1,UO_0000274,,32.0
35815,,,1137009,[],CHEMBL752185,Antimycobacterial activity against Mycobacterium tuberculosis CIP 103471,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130637,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184881,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35816,,,1137010,[],CHEMBL744962,Antimycobacterial activity against Mycobacterium avium CIP 103317,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130637,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184881,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,32.0
35817,,,1137011,[],CHEMBL752336,Antibacterial activity against Mycobacterium smegmatis CIP 103599.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130637,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184881,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,64.0
35818,,,1137012,[],CHEMBL748689,Antimycobacterial activity against Mycobacterium gordonae CIP 6427,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130637,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184881,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614986,Mycobacterium gordonae,Mycobacterium gordonae,1778.0,,,MIC,ug ml-1,UO_0000274,,32.0
35819,,,1137013,[],CHEMBL750407,Antimycobacterial activity against Mycobacterium marinum CIP 6423,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1130637,Bioorg Med Chem Lett,1998.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184881,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,,MIC,ug ml-1,UO_0000274,,16.0
35820,,,1184052,[],CHEMBL752184,In vitro anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134158,Bioorg Med Chem Lett,2001.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,191894,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.025
35821,,,1298231,[],CHEMBL751401,In vitro inhibition of Mycobacterium Tuberculosis (My 331/88) growth after 14 days culture.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134964,Bioorg Med Chem Lett,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,209270,=,1,1,=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM l-1,UO_0000065,,0.5
35822,,,1298232,[],CHEMBL751402,In vitro inhibition of Mycobacterium Tuberculosis (My 331/88) growth after 21 days culture.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134964,Bioorg Med Chem Lett,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,209270,=,1,1,=,,MIC,nM,,1000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM l-1,UO_0000065,,1.0
35823,,,1298233,[],CHEMBL751974,In vitro inhibition of Mycobacterium Kansasi (My 235/80) growth after 7 days culture.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134964,Bioorg Med Chem Lett,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,209270,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,uM l-1,UO_0000065,,250.0
35824,,,1298234,[],CHEMBL751972,In vitro inhibition of Mycobacterium Kansasi (My 235/80) growth after 14 days culture.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134964,Bioorg Med Chem Lett,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,209270,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,uM l-1,UO_0000065,,250.0
35825,,,1298235,[],CHEMBL751973,In vitro inhibition of Mycobacterium Kansasi (My 235/80) growth after 21 days culture.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134964,Bioorg Med Chem Lett,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,209270,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,uM l-1,UO_0000065,,250.0
35826,,,1298236,[],CHEMBL750547,In vitro inhibition of Mycobacterium Kansasi (My 6 509/96) growth after 7 days culture.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134964,Bioorg Med Chem Lett,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,209270,=,1,1,=,,MIC,nM,,2000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,uM l-1,UO_0000065,,2.0
35827,,,1298237,[],CHEMBL750545,In vitro inhibition of Mycobacterium Kansasi (My 6 509/96) growth after 14 days culture.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134964,Bioorg Med Chem Lett,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,209270,=,1,1,=,,MIC,nM,,2000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,uM l-1,UO_0000065,,2.0
35828,,,1298238,[],CHEMBL750546,In vitro inhibition of Mycobacterium Kansasi (My 6 509/96) growth after 21 days culture.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134964,Bioorg Med Chem Lett,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,209270,=,1,1,=,,MIC,nM,,4000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,uM l-1,UO_0000065,,4.0
35829,,,1298239,[],CHEMBL745128,In vitro inhibition of Mycobacterium Avium growth after 14 days culture.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134964,Bioorg Med Chem Lett,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,209270,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,uM l-1,UO_0000065,,250.0
35830,,,1298240,[],CHEMBL749698,In vitro inhibition of Mycobacterium Avium (My 330/88) growth after 21 days culture.,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1134964,Bioorg Med Chem Lett,2002.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,209270,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,uM l-1,UO_0000065,,250.0
35831,,,1428859,[],CHEMBL835202,Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv ATCC 27294,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143512,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367815,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35832,,,1428860,[],CHEMBL831514,Minimum inhibitory concentration against Mycobacterium tuberculosis sensitive clinical isolates; Range: 0.125-0.25 ug/ml,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143512,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367815,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35833,,,1428861,[],CHEMBL830581,Minimum inhibitory concentration against Mycobacterium tuberculosis resistant clinical isolates; Range: 8->16 ug/ml,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143512,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367815,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,16.0
35834,,,1428958,[],CHEMBL830616,Minimum inhibitory concentration against Mycobacterium avium ATCC 49601,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143512,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367815,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,16.0
35835,,,1428959,[],CHEMBL835274,Minimum inhibitory concentration against Mycobacterium intracellular ATCC 13950,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143512,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367815,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,8.0
35836,,,1429156,[],CHEMBL835160,Minimum inhibitory concentration tested against Mycobacterium tuberculosis H37Rv ATCC 27294,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143511,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367968,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35837,,,1429255,[],CHEMBL831892,Minimum inhibitory concentration tested against Mycobacterium tuberculosis sensitive clinical isolates; Range 0.125-0.25 ug/ml,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143511,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367968,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35838,,,1429256,[],CHEMBL831236,Minimum inhibitory concentration tested against Mycobacterium tuberculosis resistant clinical isolates; Range 8->16 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143511,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367968,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,16.0
35839,,,1429257,[],CHEMBL875745,Minimum inhibitory concentration tested against Mycobacterium avium ATCC 49601,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143511,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367968,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,16.0
35840,,,1429258,[],CHEMBL835273,Minimum inhibitory concentration tested against Mycobacterium intracellular ATCC 13950,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143511,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367968,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,8.0
35841,,,1429753,[],CHEMBL874293,In vitro minimum inhibitory concentration dissolved in DMSO against Mycobacterium bovis BCG using BACTEC 460 radiometric system,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142794,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,368377,=,1,0,=,,MIC99,ug ml-1,,0.1,CHEMBL613086,Mycobacterium tuberculosis variant bovis,Mycobacterium tuberculosis variant bovis,1765.0,,,MIC99,ug ml-1,UO_0000274,,0.1
35842,,,1430266,[],CHEMBL831343,Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv ATCC 27294,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142033,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367486,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35843,,,1430267,[],CHEMBL836075,Minimum inhibitory concentration against sensitive Mycobacterium tuberculosis clinical isolates; N=9; Range = 0.12-0.25,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142033,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367486,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35844,,,1430695,[],CHEMBL835440,Minimum inhibitory concentration against resistant Mycobacterium tuberculosis clinical isolates; N=9; Range=8-16,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142033,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,367486,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,16.0
35845,,,1440167,[],CHEMBL826433,Antimycobacterial activity of compound against Mycobacterium tuberculosis H37Rv at 0.05 ug/mL,F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1137114,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,372397,=,1,1,=,,Inhibition,%,,95.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Inhibition,%,UO_0000187,,95.0
35846,,,1458116,[],CHEMBL833313,Effective concentration required to reduce CFU of Mycobacterium tuberculosis Erdman (ATCC 35801) strain was determined in monolayers of mouse bone marrow macrophages,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138642,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,377780,=,1,0,=,,EC90,ug ml-1,,0.03,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,EC90,ug ml-1,UO_0000274,,0.03
35847,,,1458117,[],CHEMBL833322,Effective concentration required to reduce CFU of Mycobacterium tuberculosis Erdman (ATCC 35801) strain was determined in monolayers of mouse bone marrow macrophages,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138642,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,377780,=,1,0,=,,EC99,ug ml-1,,0.42,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,EC99,ug ml-1,UO_0000274,,0.42
35848,,,1458511,[],CHEMBL836529,Effective concentration required compared to that of Minimum inhibition concentration required against Mycobacterium tuberculosis H37Rv strain was determined; Range is 0.6-1.2,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138642,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,377780,=,1,0,=,,EC90/MIC,,,1.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,EC90/MIC,,,,1.2
35849,,,1458512,[],CHEMBL831926,Minimum inhibition concentration required against isoniazid resistant Mycobacterium tuberculosis was determined in monolayers of mouse bone marrow macrophages,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138642,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,377780,>,1,1,>,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
35850,,,1458513,[],CHEMBL830395,Minimum bactericidal concentration required against Mycobacterium tuberculosis H37Rv strain was determined in monolayers of mouse bone marrow macrophages,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138642,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,377780,=,1,0,=,,MBC,ug ml-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MBC,ug ml-1,UO_0000274,,0.1
35851,,,1458514,[],CHEMBL831199,Minimum bactericidal required against isoniazid resistant Mycobacterium tuberculosis was determined in monolayers of mouse bone marrow macrophages,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138642,Bioorg Med Chem Lett,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,377780,>,1,0,>,,MBC,ug ml-1,,1.6,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MBC,ug ml-1,UO_0000274,,1.6
35852,,,1471225,[],CHEMBL837228,Viable Mycobacterium tuberculosis in lungs of infected Mice after an 8-day drug treatment; Dose is 25 mg/kg,F,,,BAO_0000181,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138787,J Med Chem,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,380795,=,1,0,=,,Activity,log CFU,,5.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log CFU,,,5.5
35853,,,1471226,[],CHEMBL834915,Viable Mycobacterium tuberculosis in spleen of infected Mice after an 8-day drug treatment; Dose is 25 mg/kg,F,,,BAO_0000181,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138787,J Med Chem,2004.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,380795,=,1,0,=,,Activity,log CFU,,3.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log CFU,,,3.2
35854,,,1477840,[],CHEMBL834664,Minimum inhibitory concentration against Mycobacterium tuberculosis H37Rv pFPCA1 in green fluorescent protein microplate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142818,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,382460,<,1,1,<,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
35855,,,1497789,[],CHEMBL831241,In vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv in broth cluture infected with macrophages; Range 0.025-0.05,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.05
35856,,Not Determined,1497790,[],CHEMBL835053,In vitro antimycobacterial activity against rifampin-resistant Mycobacterium tuberculosis strain; nd= not determined,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,,1,0,,,MIC,ug.mL-1,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,
35857,,Not Determined,1497791,[],CHEMBL835373,In vitro antimycobacterial activity against ethionamide-resistant Mycobacterium tuberculosis strain; nd= not determined,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,,1,0,,,MIC,ug.mL-1,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,
35858,,Not Determined,1497792,[],CHEMBL835088,In vitro antimycobacterial activity against thiacetazone resistant Mycobacterium tuberculosis strain; nd= not determined,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,,1,0,,,MIC,ug.mL-1,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,
35859,,,1497793,[],CHEMBL831183,In vitro antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis strain ,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,>,1,0,>,,MBC,ug ml-1,,1.6,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MBC,ug ml-1,UO_0000274,,1.6
35860,,Not Determined,1497794,[],CHEMBL831195,In vitro antimycobacterial activity against rifampin-resistant Mycobacterium tuberculosis strain; nd= not determined,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,388650,,1,0,,,MBC,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MBC,ug ml-1,,,
35861,,Not Determined,1497795,[],CHEMBL831038,In vitro antimycobacterial activity against Mycobacterium tuberculosis Erdman in broth cluture infected with macrophages;nd = not determined,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,,1,0,,,MIC,ug.mL-1,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,
35862,,,1497796,[],CHEMBL825821,Selective index of IC50 of Vero Cells to that of MIC of Mycobacterium tuberculosis H37Rv,F,,,BAO_0000179,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,388650,>,1,0,>,,Selective index,,,20000.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,Selective index,,,,20000.0
35863,,,1497797,[],CHEMBL833166,Effective concentration required for the reduction in colony forming units (CFU) at seven days compared to drug free controls,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,=,1,0,=,,EC90,ug ml-1,,0.03,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,EC90,ug ml-1,UO_0000274,,0.03
35864,,,1497798,[],CHEMBL833319,Effective concentration required for the reduction in colony forming units (CFU) at seven days compared to drug free controls,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,=,1,0,=,,EC99,ug ml-1,,0.42,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,EC99,ug ml-1,UO_0000274,,0.42
35865,,Not Determined,1497799,[],CHEMBL826804,Ratio of effective concentration required for the reduction in colony forming units (CFU) at seven days compared to drug free controls to that of MIC against Mycobacterium tuberculosis Erdman;nd= not determined,F,,,BAO_0000193,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,388650,,1,0,,,Ratio,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Ratio,,,,
35866,,,1497800,[],CHEMBL831196,In vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv in broth cluture infected with macrophages,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,=,1,0,=,,MBC,ug ml-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MBC,ug ml-1,UO_0000274,,0.1
35867,,,1497801,[],CHEMBL831444,Minimum inhibitory concentration against isoniazid-resistant Mycobacterium tuberculosis strain ,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,>,1,1,>,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
35868,,Not Determined,1497802,[],CHEMBL835048,Minimum inhibitory concentration against ethambutol-resistant Mycobacterium tuberculosis strain; nd= not determined,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145244,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,388650,,1,0,,,MIC,ug.mL-1,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,
35869,,,1610788,[],CHEMBL881906,Calculated partition coefficient (ClogP) of the compound,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,NNC(=O)c1ccncc1,,,CHEMBL1142849,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,403263,-,1,1,,,CLogP,,,0.58,CHEMBL2362975,,No relevant target,,,,ClogP,,,,0.58
35870,,,1610789,[],CHEMBL883831,In vitro minimal inhibitory concentration against Mycobacterium tuberculosis [H37Rv stain],F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142849,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,403263,=,1,1,=,,MIC,nM,,2040.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,2.04
35871,,,1610790,[],CHEMBL885133,In vitro inhibitory concentration against Mycobacterium tuberculosis [H37Rv stain],F,,,BAO_0000190,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142849,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,403263,>,1,1,>,,IC50,nM,,45570.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,IC50,uM,UO_0000065,,45.57
35872,,,1610791,[],CHEMBL883606,Log CFU in lungs of mice infected with H37Rv stain of Mycobacterium tuberculosis after administration at 25 mg/Kg,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142849,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,403263,=,1,0,=,,Log CFU,,,6.38,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log CFU,,,,6.38
35873,,,1652838,[],CHEMBL860322,Viable number of Mycobacterium tuberculosis colonies in lungs of infected mice after 9 days of administration of 300 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1140435,J Med Chem,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,406836,=,1,0,=,,Log10 cfu,,,3.88,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,3.88
35874,,,1653372,[],CHEMBL859213,Activity against Mycobacterium tuberculosis in the absence of mouse serum,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1140435,J Med Chem,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,406836,=,1,1,=,,MIC50,ug.mL-1,,41.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,mg/ml,UO_0000274,,0.041
35875,,,1653373,[],CHEMBL860316,Activity against Mycobacterium tuberculosis H37Rv in presence of 10% mouse serum,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1140435,J Med Chem,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,406836,=,1,1,=,,MIC50,ug.mL-1,,120.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,mg/ml,UO_0000274,,0.12
35876,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1653374,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '300.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '300.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL859215,"Maximum concentration in female C57BL/6 mice administered with 300 mg/kg, po",A,,,BAO_0002119,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1140435,J Med Chem,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,406836,>,1,1,>,,Cmax,nM,,280005833.45,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,mg/ml,UO_0000065,,38.4
35877,,Not Determined,1653375,[],CHEMBL859214,"Tmax in female C57BL/6 mice administered with 300 mg/kg, po",A,,,BAO_0003037,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1140435,J Med Chem,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,406836,,1,0,,,Tmax,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,,,,
35878,,Not Determined,1653376,[],CHEMBL859216,"Half life in female C57BL/6 mice administered with 300 mg/kg, po",A,,,BAO_0002115,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1140435,J Med Chem,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,406836,,1,0,,,T1/2,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T1/2,,,,
35879,,,1653377,[],CHEMBL859217,"Oral bioavailability in female C57BL/6 mice administered with 300 mg/kg, po",A,,,BAO_0003042,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1140435,J Med Chem,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,406836,>,1,1,>,,F,%,,80.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,F,%,UO_0000187,,80.0
35880,,,1659204,[],CHEMBL861610,Antitubercular activity against Mycobacterium tuberculosis H37Rv by agar microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1141943,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,411096,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.05
35881,,,1659219,[],CHEMBL861612,Antitubercular activity against Mycobacterium tuberculosis H37Rv by standard BACTEC radiometric growth assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1141943,Bioorg Med Chem Lett,2005.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,411096,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.025
35882,,Not Determined,1667170,[],CHEMBL864616,Inhibitory activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0003035,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148589,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,417916,,1,0,,,MIC50,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,,,,
35883,,,1667198,[],CHEMBL864616,Inhibitory activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148589,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Micromolar,417916,=,1,0,=,,MIC99,uM,,0.18,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC99,uM,UO_0000064,,0.18
35884,,,1679442,[],CHEMBL867122,Inhibition of mammalian Vero cell viability at 6.25 and 62.5 ug/ml by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1149454,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,427204,>,1,1,>,,IC50,nM,,454700.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,uM,UO_0000065,,454.7
35885,,,1679448,[],CHEMBL867123,Antibacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149454,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,427204,=,1,1,=,,MIC,nM,,1460.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.46
35886,,,1679454,[],CHEMBL867124,Antibacterial activity against INH-resistant Mycobacterium tuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149454,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,427204,=,1,1,=,,MIC,nM,,90940.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,90.94
35887,,,1681033,[],CHEMBL858927,Toxicity towards human mononuclear leucocytes at 1 mM,T,,,BAO_0001103,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1149410,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,424755,=,1,0,=,,Activity,%,,12.4,CHEMBL613107,Homo sapiens,PBMC,9606.0,,,Activity,%,UO_0000187,,12.4
35888,,,1717813,[],CHEMBL869356,Reduction in CFU in C57BL/6 mouse infected with 10^5 CFU of Mycobacterium tuberculosis H37Rv at 10 mg/kg after 20 days,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1147721,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,477359,=,1,0,=,,Log10 cfu,,,3.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,3.5
35889,,,1720692,[],CHEMBL863124,Cytotoxicity against Vero cell line,F,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1148530,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,491478,>,1,1,>,,IC50,ug.mL-1,,62.5,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,ug ml-1,UO_0000274,,62.5
35890,,,1720712,[],CHEMBL863125,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148530,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,491478,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.05
35891,,,1720732,[],CHEMBL863126,Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148530,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,491478,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.56
35892,,,1720765,[],CHEMBL867512,"Activity against Mycobacterium tuberculosis H37Rv infected in CD1 mouse assessed as decrease in bacterial load relative to control in lung at 25 mg/kg, ip",F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148530,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,491478,=,1,0,=,,Log10 cfu,,,5.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,5.12
35893,,,1720766,[],CHEMBL867514,"Activity against Mycobacterium tuberculosis H37Rv infected in CD1 mouse assessed as decrease in bacterial load relative to control in spleen at 25 mg/kg, ip",F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148530,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,491478,=,1,0,=,,Log10 cfu,,,4.11,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,4.11
35894,,,1752197,[],CHEMBL867973,Cytotoxicity against Vero cell line,F,,,BAO_0000179,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1145326,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,531426,=,1,0,=,,Maximal non-toxic dose 50,ug ml-1,,32.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,Maximal non-toxic dose 50,ug ml-1,UO_0000274,,32.0
35895,,,1752231,[],CHEMBL867977,Antibacterial activity against Mycobacterium smegmatis,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145326,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,531426,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,64.0
35896,,,1752259,[],CHEMBL867976,Antibacterial activity against Mycobacterium marinum,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145326,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,531426,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,,MIC,ug ml-1,UO_0000274,,16.0
35897,,,1752299,[],CHEMBL867975,Antibacterial activity against Mycobacterium avium,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145326,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,531426,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,32.0
35898,,,1752406,[],CHEMBL867974,"Protection index, cytotoxicity against Vero cell line/antibacterial activity against Mycobacterium tuberculosis 103471",F,,,BAO_0000179,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1145326,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,531426,=,1,0,=,,PI,,,128.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,PI,,,,128.0
35899,,,1752480,[],CHEMBL867972,Antibacterial activity against Mycobacterium tuberculosis 103471,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145326,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,531426,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
35900,,,1758678,[],CHEMBL868579,Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146010,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,537916,=,1,1,=,,MIC,nM,,11370.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,11.37
35901,,,1758697,[],CHEMBL868578,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146010,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,537916,=,1,1,=,,MIC,nM,,730.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.73
35902,,,1762170,[],CHEMBL911527,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by BACTEC-460 radiometric assay at 6.25 ug/ml,F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146905,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,558799,=,1,1,=,,Inhibition,%,,96.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Inhibition,%,UO_0000187,,96.0
35903,,,1762181,[],CHEMBL912069,Antimycobacterial activity against INH-resistant Mycobacterium tuberculosis by agar dilution method at 6.25 ug/ml,F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146905,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,558799,=,1,1,=,,Inhibition,%,,90.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Inhibition,%,UO_0000187,,90.0
35904,,,1762275,[],CHEMBL912158,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by BACTEC-460 radiometric assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146905,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,558799,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.1
35905,,,1762276,[],CHEMBL912159,Antimycobacterial activity against INH-resistant Mycobacterium tuberculosis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146905,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,558799,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.56
35906,,,1768927,[],CHEMBL912112,Antitubercular activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1149509,Bioorg Med Chem Lett,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,581943,=,1,1,=,,MIC,ug.mL-1,,0.65,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.65
35907,,Not Determined,1805402,[],CHEMBL911945,Inhibition of Mycobacterium tuberculosis MbtA by [32P]PPi-ATP exchange assay,B,,,BAO_0000179,BAO_0000357,single protein format,NNC(=O)c1ccncc1,,,CHEMBL1138866,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,621827,,1,0,,,Ki app,,,,CHEMBL5662,Mycobacterium tuberculosis,"2,3-dihydroxybenzoate-AMP ligase",1773.0,,,Ki app,,,,
35908,,,1805404,[],CHEMBL913020,Antitubercular activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138866,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Micromolar,621827,=,1,0,=,,MIC99,uM,,0.18,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC99,uM,UO_0000064,,0.18
35909,,Not Determined,1805406,[],CHEMBL913021,Inhibitory activity against Yersinia pseudotuberculosis ATCC 6902,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138866,J Med Chem,2006.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,621827,,1,0,,,MIC99,,,,CHEMBL613185,Yersinia pseudotuberculosis,Yersinia pseudotuberculosis,633.0,,,MIC99,,,,
35910,,Active,1836941,[],CHEMBL918503,"Clearance of Mycobacterium tuberculosis H37Rv in BALB/c mouse lung at 25 mg/kg, po five times/week after 1 month relative to control",F,,,BAO_0000375,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142207,Antimicrob Agents Chemother,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,626013,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
35911,,Active,1836942,[],CHEMBL918504,"Clearance of Mycobacterium tuberculosis H37Rv in BALB/c mouse spleen at 25 mg/kg, po five times/week after 1 month relative to control",F,,,BAO_0000375,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142207,Antimicrob Agents Chemother,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,626013,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
35912,,,1847825,[],CHEMBL920053,"Reduction of bacterial counts in Mycobacterium tuberculosis H37Rv infected Swiss mouse lung at 25 mg/kg, po for 5 days/week after 1 month",F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142073,Antimicrob Agents Chemother,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,632058,=,1,0,=,,Log10 cfu,,,4.9,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,4.9
35913,,,1847826,[],CHEMBL920054,"Reduction of bacterial counts in Mycobacterium tuberculosis H37Rv infected Swiss mouse lung at 25 mg/kg, po for 5 days/week after 2 months",F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142073,Antimicrob Agents Chemother,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,632058,=,1,0,=,,Log10 cfu,,,4.7,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,4.7
35914,,Active,1847831,[],CHEMBL920062,"Reduction of lung lesions in Mycobacterium tuberculosis H37Rv infected Swiss mouse at 25 mg/kg, po for 5 days/week after 2 months",F,,,BAO_0000375,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142073,Antimicrob Agents Chemother,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,632058,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
35915,,,1865553,[],CHEMBL914255,Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by microplate Alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1139892,J Nat Prod,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,636233,=,1,1,=,,MIC,nM,,290.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.29
35916,,,1866414,[],CHEMBL920153,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed by relative light units after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,634675,<=,1,1,<=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.5
35917,,,1866443,[],CHEMBL920154,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed as bacterial density after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,634675,<=,1,1,<=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.5
35918,,,1866472,[],CHEMBL920155,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as relative light unit after 11 days by LORA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,634675,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
35919,,,1866501,[],CHEMBL920156,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as bacterial density after 10 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,634675,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
35920,,,1870230,[],CHEMBL904526,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142873,Eur J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,636283,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.025
35921,,,1876034,[],CHEMBL904121,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,637321,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.025
35922,,,1876035,[],CHEMBL904121,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0000190,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,637321,>,1,1,>,,IC50,ug.mL-1,,100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,IC50,ug ml-1,UO_0000274,,100.0
35923,,,1876067,[],CHEMBL904124,Antimycobacterial activity against Mycobacterium tuberculosis 331/88 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637321,=,1,1,=,,MIC,nM,,1000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,umol/L,UO_0000065,,1.0
35924,,,1876077,[],CHEMBL904125,Antimycobacterial activity against Mycobacterium avium 330/88 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637321,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,umol/L,UO_0000065,,250.0
35925,,,1876087,[],CHEMBL904126,Antimycobacterial activity against Mycobacterium kansasii 235/80 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637321,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,250.0
35926,,,1876105,[],CHEMBL904128,Antimycobacterial activity against Mycobacterium tuberculosis 331/88 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637321,=,1,1,=,,MIC,nM,,1000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,umol/L,UO_0000065,,1.0
35927,,,1876115,[],CHEMBL904129,Antimycobacterial activity against Mycobacterium avium 330/88 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637321,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,umol/L,UO_0000065,,250.0
35928,,,1876125,[],CHEMBL904130,Antimycobacterial activity against Mycobacterium kansasii 235/80 after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637321,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,250.0
35929,,,1876135,[],CHEMBL904131,Antimycobacterial activity against Mycobacterium kansasii 235/80 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637321,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,250.0
35930,,,1876160,[],CHEMBL904133,Antimycobacterial activity against Mycobacterium kansasii 6509/96 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637321,=,1,1,=,,MIC,nM,,4000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,4.0
35931,,,1876161,[],CHEMBL904132,Antimycobacterial activity against Mycobacterium kansasii 6509/96 after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637321,=,1,1,=,,MIC,nM,,2000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,2.0
35932,,,1876162,[],CHEMBL904127,Antimycobacterial activity against Mycobacterium kansasii 6509/96 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1142926,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637321,=,1,1,=,,MIC,nM,,4000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,4.0
35933,,,1876732,[],CHEMBL904187,Antimicrobial activity against Mycobacterium tuberculosis My 331/88 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143019,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637418,=,1,1,=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,umol/L,UO_0000065,,0.5
35934,,,1876752,[],CHEMBL904188,Antimicrobial activity against Mycobacterium tuberculosis My 331/88 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143019,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637418,=,1,1,=,,MIC,nM,,1000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,umol/L,UO_0000065,,1.0
35935,,,1876772,[],CHEMBL904189,Antimicrobial activity against Mycobacterium avium My 330/88 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143019,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637418,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,umol/L,UO_0000065,,250.0
35936,,,1876792,[],CHEMBL904190,Antimicrobial activity against Mycobacterium avium My 330/88 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143019,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637418,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,umol/L,UO_0000065,,250.0
35937,,,1876812,[],CHEMBL904191,Antimicrobial activity against Mycobacterium kansasii My 235/80 after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143019,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637418,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,250.0
35938,,,1876832,[],CHEMBL904192,Antimicrobial activity against Mycobacterium kansasii My 235/80 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143019,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637418,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,250.0
35939,,,1876852,[],CHEMBL904193,Antimicrobial activity against Mycobacterium kansasii My 235/80 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143019,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637418,>,1,1,>,,MIC,nM,,250000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,250.0
35940,,,1876871,[],CHEMBL904194,Antimicrobial activity against Mycobacterium kansasii My 6509/96 after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143019,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637418,=,1,1,=,,MIC,nM,,4000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,4.0
35941,,,1876891,[],CHEMBL904195,Antimicrobial activity against Mycobacterium kansasii My 6509/96 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143019,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637418,=,1,1,=,,MIC,nM,,4000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,4.0
35942,,,1876910,[],CHEMBL904196,Antimicrobial activity against Mycobacterium kansasii My 6509/96 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143019,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,637418,=,1,1,=,,MIC,nM,,8000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,8.0
35943,,,1887302,[],CHEMBL906571,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143736,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,639674,=,1,1,=,,MIC,nM,,440.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.44
35944,,,1887315,[],CHEMBL906572,Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis CIBIN 687 isolates,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143736,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,639674,=,1,1,=,,MIC,nM,,910.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.91
35945,,,1887329,[],CHEMBL906573,Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis CIBIN 650 isolates,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143736,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,639674,=,1,1,=,,MIC,nM,,910.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.91
35946,,,1887344,[],CHEMBL906574,Antimycobacterial activity against streptomycin and isoniazid-resistant Mycobacterium tuberculosis CIBIN 675 isolates,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143736,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,639674,=,1,1,=,,MIC,nM,,29190.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,29.19
35947,,,1887359,[],CHEMBL906575,"Antimycobacterial activity against streptomycin, isoniazid, rifampicin, pyrazinamide-resistant Mycobacterium tuberculosis CIBIN 234 isolates",F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143736,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,639674,=,1,1,=,,MIC,nM,,58380.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,58.38
35948,,,1887375,[],CHEMBL906576,"Antimycobacterial activity against streptomycin, isoniazid, ethambutol-resistant Mycobacterium tuberculosis CIBIN 112 isolates",F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143736,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,639674,=,1,1,=,,MIC,nM,,29190.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,29.19
35949,,,1887394,[],CHEMBL906577,Cytotoxicity against Vero cells,A,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1143736,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,4.4,0,http://www.openphacts.org/units/Nanomolar,639674,=,1,1,=,,IC50,nM,,39800.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,uM,UO_0000065,,39.8
35950,,,1887412,[],CHEMBL906578,Toxicity against non-adherent human PBMC,T,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1143736,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,639674,=,1,1,=,,IC50,ug.mL-1,,87.08,CHEMBL613107,Homo sapiens,PBMC,9606.0,,,IC50,ug ml-1,UO_0000274,,87.08
35951,,,1887413,[],CHEMBL906580,Survival of adherent human PBMC at 100 ug/mL,F,,,BAO_0000179,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1143736,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,639674,>,1,0,>,,Survival,%,,95.0,CHEMBL613107,Homo sapiens,PBMC,9606.0,,,Survival,%,UO_0000187,,95.0
35952,,,1887414,[],CHEMBL906579,Toxicity against adherent human PBMC,T,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1143736,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,639674,>,1,1,>,,IC50,ug.mL-1,,100.0,CHEMBL613107,Homo sapiens,PBMC,9606.0,,,IC50,ug ml-1,UO_0000274,,100.0
35953,,,1891303,[],CHEMBL905916,Antimicrobial activity against Mycobacterium smegmatis str. MC2 155 after 24 hrs at 1 ug/ml by broth dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143791,Eur J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,640680,=,1,0,=,,Activity,%,,36.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,Activity,%,UO_0000187,,36.0
35954,,,1891307,[],CHEMBL905914,Antimicrobial activity against Mycobacterium smegmatis str. MC2 155 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1143791,Eur J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,640680,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,1.5
35955,,,1896161,[],CHEMBL887385,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1144609,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,641616,=,1,1,=,,MIC,nM,,720.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.72
35956,,,1896193,[],CHEMBL887386,Cytotoxicity against Vero cells after 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1144609,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,641616,>,1,1,>,,IC50,nM,,455770.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,uM,UO_0000065,,455.77
35957,,,1910763,[],CHEMBL890626,Antibacterial activity against Escherichia coli ATCC 25922 after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,100.0
35958,,,1910770,[],CHEMBL890627,Antibacterial activity against Enterobacter aerogenes after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,100.0
35959,,,1910778,[],CHEMBL890628,Antibacterial activity against Proteus vulgaris ATCC 49132 after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,100.0
35960,,,1910785,[],CHEMBL890629,Antibacterial activity against Pseudomonas aeruginosa ATCC 13048 after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,100.0
35961,,,1910792,[],CHEMBL890630,Antibacterial activity against Salmonella Typhimurium after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,100.0
35962,,,1910806,[],CHEMBL890631,Antibacterial activity against Staphylococcus epidermidis ATCC 14990 after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,100.0
35963,,,1910817,[],CHEMBL890632,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
35964,,,1910821,[],CHEMBL890635,Antibacterial activity against Bacillus subtilis ATCC 6633 after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
35965,,,1910834,[],CHEMBL890636,Antibacterial activity Listeria monocytogenes ATCC 15313 after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,100.0
35966,,,1910844,[],CHEMBL890637,Antibacterial activity Streptococcus pyogenes ATCC 19615 after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,100.0
35967,,,1910854,[],CHEMBL890638,Antibacterial activity Streptococcus pneumoniae ATCC 49619 after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,100.0
35968,,,1910863,[],CHEMBL890639,Antibacterial activity Enterococcus faecalis ATCC 29212 after 16 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,645158,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,100.0
35969,,,1910889,[],CHEMBL890643,Antimycobacterial activity against drug-resistant Mycobacterium tuberculosis H37Rv at 1mg/mL by BACTEC assay,F,,,BAO_0000201,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1146217,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,645158,=,1,1,=,,Inhibition,%,,100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Inhibition,%,UO_0000187,,100.0
35970,,,1915250,[],CHEMBL894285,Antibacterial activity against Mycobacterium tuberculosis H37Rv after 18 hrs by agar plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148727,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,653856,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.1
35971,,,1915251,[],CHEMBL894284,Antibacterial activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv after 18 hrs by agar plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148727,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,653856,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,25.0
35972,,,1915252,[],CHEMBL894288,Antibacterial activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv after 18 hrs by agar plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148727,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,653856,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.05
35973,,,1915253,[],CHEMBL893269,Antibacterial activity against Mycobacterium bovis BCG Tokyo after 18 hrs by agar plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148727,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,653856,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL615052,Mycobacterium tuberculosis variant bovis BCG,Mycobacterium tuberculosis variant bovis BCG,33892.0,,,MIC,ug ml-1,UO_0000274,,0.1
35974,,,1915254,[],CHEMBL893270,Antibacterial activity against Mycobacterium avium Flamingo after 18 hrs by agar plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148727,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,653856,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,25.0
35975,,,1915255,[],CHEMBL893271,Antibacterial activity against Mycobacterium intracellular ATCC 15984 after 18 hrs by agar plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148727,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,653856,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,12.5
35976,,,1915258,[],CHEMBL894287,Antibacterial activity against Mycobacterium aurum after 18 hrs by agar plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148727,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,653856,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL612952,Mycolicibacterium aurum,Mycolicibacterium aurum,1791.0,,,MIC,ug ml-1,UO_0000274,,6.3
35977,,,1915260,[],CHEMBL893272,Antibacterial activity against Mycobacterium fortuitum NIHJ1615 after 18 hrs by agar plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148727,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,653856,=,1,1,=,,MIC,ug.mL-1,,6.3,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,ug ml-1,UO_0000274,,6.3
35978,,,1915261,[],CHEMBL893273,Antibacterial activity against Mycobacterium smegmatis Takeo after 18 hrs by agar plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148727,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,653856,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,12.5
35979,,,1956124,[],CHEMBL891915,Antibacterial activity against Mycobacterium tuberculosis H37Rv after 2 weeks by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1147864,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,650244,=,1,1,=,,MIC,ug.mL-1,,0.075,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.075
35980,,,1956142,[],CHEMBL891916,Antibacterial activity against Mycobacterium avium 724S after 2 weeks by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1147864,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,650244,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,12.5
35981,,,1956159,[],CHEMBL891917,Antibacterial activity against Staphylococcus aureus after 2 weeks by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1147864,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,650244,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
35982,,,1956176,[],CHEMBL891918,Antibacterial activity against methicillin-resistant Staphylococcus aureus 873 after 2 weeks by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1147864,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,650244,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
35983,,,1956193,[],CHEMBL891919,Antibacterial activity against methicillin-resistant Staphylococcus aureus 906 after 2 weeks by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1147864,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,650244,>,1,1,>,,MIC,ug.mL-1,,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/ml,UO_0000274,,100.0
35984,,,1956210,[],CHEMBL891920,Antibacterial activity against methicillin-resistant Staphylococcus aureus 908 after 2 weeks by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1147864,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,650244,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
35985,,,1956231,[],CHEMBL891921,Antibacterial activity against methicillin-resistant Staphylococcus aureus 910 after 2 weeks by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1147864,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,650244,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
35986,,,1962322,[],CHEMBL893559,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method using double dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148026,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,652804,=,1,1,=,,MIC,nM,,730.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.73
35987,,,1962323,[],CHEMBL893560,Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis by agar dilution method using double dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1148026,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,652804,=,1,1,=,,MIC,nM,,11370.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,11.37
35988,,,1989425,[],CHEMBL899120,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1137533,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,663665,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
35989,,,1989452,[],CHEMBL899121,Cytotoxicity against Vero cells after 48 hrs by XTT method,A,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137533,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,663665,>,1,1,>,,IC50,ug.mL-1,,200.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,ug ml-1,UO_0000274,,200.0
35990,,,1989478,[],CHEMBL899122,"Selectivity index, ratio of IC50 for Vero cells to MIC of Mycobacterial tuberculosis H37Rv",F,,,BAO_0000193,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,,,CHEMBL1137533,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,663665,>,1,0,>,,Ratio,,,1000.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,1000.0
35991,,,1989526,[],CHEMBL899126,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv at MIC,F,,,BAO_0001103,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1137533,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://qudt.org/vocab/unit#Percent,663665,=,1,0,=,,Activity,%,,99.9,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,%,UO_0000187,,99.9
35992,,,2002064,[],CHEMBL900652,Cytotoxicity against Vero cells after 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,NNC(=O)c1ccncc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1138270,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,666360,>,1,1,>,,IC50,nM,,455800.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,uM,UO_0000065,,455.8
35993,,,2002119,[],CHEMBL901695,Antimycobacterial activity against multi-drug-resistant Mycobacterium tuberculosis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138270,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,666360,=,1,1,=,,MIC,nM,,45570.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,45.57
35994,,,2002170,[],CHEMBL901697,Antimicrobial activity against Mycobacterium smegmatis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138270,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,666360,=,1,1,=,,MIC,nM,,45570.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,45.57
35995,,,2002221,[],CHEMBL901696,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138270,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/Nanomolar,666360,=,1,1,=,,MIC,nM,,360.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.36
35996,,,2002278,[],CHEMBL901699,"Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35801 infected CD1 mouse assessed as lung bacterial count at 25 mg/kg, ip after 35 days post infection",F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138270,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,666360,=,1,0,=,,Log10 cfu,,,5.86,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,5.86
35997,,,2002280,[],CHEMBL901701,"Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35801 infected CD1 mouse assessed as spleen bacterial count at 25 mg/kg, ip after 35 days post infection",F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138270,J Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,666360,=,1,0,=,,Log10 cfu,,,4.71,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,4.71
35998,,,2003391,[],CHEMBL901892,Antibacterial activity against Mycobacterium tuberculosis ATTC 27294 after 5 days by MABA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1138286,Bioorg Med Chem Lett,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,666634,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
35999,,,2019086,[],CHEMBL903192,Antimycobacterial activity against Mycobacterium smegmatis mc2155 after 48 hrs by microdilution resazurin assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NNC(=O)c1ccncc1,,,CHEMBL1139091,Bioorg Med Chem,2007.0,,CHEMBL64,ISONIAZID,CHEMBL64,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,670572,=,1,0,=,,MIC95,ug ml-1,,12.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC95,ug ml-1,UO_0000274,,12.0
